RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals

Int J Geriatr Psychiatry 17(7):635-640 · 2002 · PMID 12112161

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

1,526편 검색→1,511편 판독→710편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Apolipoprotein E epsilon4 allele and cognitive function in cognitively normal older adults (("Apolipoprotein E"[tiab] OR APOE[tiab] OR "apo E"[tiab] OR "apolipoprotein E4"[tiab]) AND (epsilon4[tiab] OR "ε4"[tiab] OR "e4 allele"[tiab] OR APOE4[tiab] OR "ε4 allele"[tiab]) AND ("cognitive function"[tiab] OR cognition[tiab] OR cognitive[tiab] OR "cognitive performance"[tiab] OR "memory performance"[tiab]) AND ("cognitively normal"[tiab] OR "cognitively unimpaired"[tiab] OR "healthy older adults"[tiab] OR "normal cognition"[tiab] OR "cognitively healthy"[tiab] OR "older adults"[tiab]))

출판 연도

1998: 3편319981999: 2편22000: 2편22001: 1편12002: 4편42003: 1편12004: 3편32005: 8편820052006: 4편42007: 8편82008: 3편32009: 14편142010: 16편1620102011: 14편142012: 20편202013: 23편232014: 23편232015: 32편3220152016: 19편192017: 32편322018: 44편442019: 38편382020: 41편4120202021: 56편562022: 43편432023: 57편572024: 58편582025: 75편752026: 66편662026

선별된 710편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01memory · performance194편

  1. 0.95

    Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE epsilon4 and Is Detectable over 18-Months

    Thai C, Lim YY, Villemagne VL et al. · PloS one · 2015

  2. 0.95

    Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly

    Luck T, Then FS, Luppa M et al. · Neuropsychology · 2015

  3. 0.95

    Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly

    Dik MG, Jonker C, Comijs HC et al. · Neurology · 2001

  4. 0.95

    Apolipoprotein E epsilon4 Allele Is Associated with Reduced Retention of the "Where" Memory Component in Cognitively Intact Older Adults

    Chi CH, Chiu YS, Chang YL · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2020

  5. 0.95

    Apolipoprotein E epsilon4 allele effects on longitudinal cognitive trajectories are sex and age dependent

    Williams OA, An Y, Armstrong NM et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019

  6. 0.95

    Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele

    Caselli RJ, Reiman EM, Osborne D et al. · Neurology · 2004

  7. 0.94

    Change in cognitive functioning associated with apoE genotype in a community sample of older adults

    Hofer SM, Christensen H, Mackinnon AJ et al. · Psychology and aging · 2002

  8. 0.94

    Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults

    Swan GE, Lessov-Schlaggar CN, Carmelli D et al. · Journal of geriatric psychiatry and neurology · 2005

  9. 0.94

    Deficits in inhibition and flexibility are associated with the APOE-E4 allele in nondemented older adults

    Wetter SR, Delis DC, Houston WS et al. · Journal of clinical and experimental neuropsychology · 2005

  10. 0.94

    The Association of Apolipoprotein E Gene Polymorphism With Cognitive Performance in Nondemented Polish Adults Aged 55 to 75

    Piskunowicz MT, Linkowska K, Golota S et al. · International journal of aging & human development · 2018

  11. 0.94

    Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals

    Pettigrew C, Nazarovs J, Soldan A et al. · Alzheimer's research & therapy · 2023

  12. 0.94

    Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease

    Schoemaker D, Poirier J, Escobar S et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2016

  13. 0.94

    Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?

    Small BJ, Graves AB, McEvoy CL et al. · Neurology · 2000

  14. 0.94

    Amyloid-beta and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score

    Tomassen J, den Braber A, van der Lee SJ et al. · BMC neurology · 2022

  15. 0.93

    Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle

    Sapkota S, Backman L, Dixon RA · Neurobiology of aging · 2017

  16. 0.93

    Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: verbal versus design fluency

    Houston WS, Delis DC, Lansing A et al. · Journal of the International Neuropsychological Society : JINS · 2005

  17. 0.93

    Short-term adverse effects of the apolipoprotein E epsilon4 allele over language function and executive function in healthy older adults

    Li W, Qiu Q, Sun L et al. · Neuropsychiatric disease and treatment · 2019

  18. 0.93

    Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults

    Lee BK, Glass TA, Wand GS et al. · The American journal of psychiatry · 2008

  19. 0.93

    Effects of APOEvarepsilon4 genotype on age-associated change in cognitive functions among Japanese middle-aged and older adults: A 20-year follow-up study

    Nishita Y, Sala G, Shinohara M et al. · Experimental gerontology · 2023

  20. 0.93

    Past and future episodic detail retrieval is reduced among clinically normal older adults at higher genetic risk for late-onset Alzheimer's disease

    Acevedo-Molina MC, Thayer SC, Horn K et al. · Neuropsychology · 2023

  21. 0.93

    Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study

    Du M, Andersen SL, Schupf N et al. · Journal of Alzheimer's disease : JAD · 2021

  22. 0.93

    Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect

    Caselli RJ, Dueck AC, Osborne D et al. · The New England journal of medicine · 2009

  23. 0.93

    The neuropsychology of normal aging and preclinical Alzheimer's disease

    Caselli RJ, Locke DEC, Dueck AC et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

  24. 0.93

    Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults

    Pendleton N, Payton A, van den Boogerd EH et al. · Neuroscience letters · 2002

  25. 0.93

    Effects of APOE on cognitive aging in community-dwelling older adults

    Reas ET, Laughlin GA, Bergstrom J et al. · Neuropsychology · 2019

  26. 0.93

    Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype

    Chapman BP, Benedict RHB, Lin F et al. · International journal of geriatric psychiatry · 2018

  27. 0.93

    Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness

    Etnier JL, Caselli RJ, Reiman EM et al. · Medicine and science in sports and exercise · 2007

  28. 0.92

    Gene by neuroticism interaction and cognitive function among older adults

    Dar-Nimrod I, Chapman BP, Robbins JA et al. · International journal of geriatric psychiatry · 2012

  29. 0.92

    APOE4 Status and Cognitive Function in Middle-aged and Elderly People

    Pavel NA, Paun MR, Matei PV et al. · Balkan journal of medical genetics : BJMG · 2022

  30. 0.92

    Longitudinal cognitive decline in the AIBL cohort: The role of APOE epsilon4 status

    Albrecht MA, Szoeke C, Maruff P et al. · Neuropsychologia · 2015

  31. 0.92

    Self-reference and emotional memory effects in older adults at increased genetic risk of Alzheimer's disease

    Grilli MD, Woolverton CB, Crawford M et al. · Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2018

  32. 0.92

    Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease

    Baxter LC, Caselli RJ, Johnson SC et al. · Neurobiology of aging · 2003

  33. 0.92

    Interactive effect of APOE genotype and blood pressure on cognitive decline: the PATH through life study

    Andrews S, Das D, Anstey KJ et al. · Journal of Alzheimer's disease : JAD · 2015

  34. 0.92

    Apolipoprotein E, B vitamins, and cognitive function in older adults

    Bunce D, Kivipelto M, Wahlin A · The journals of gerontology. Series B, Psychological sciences and social sciences · 2005

  35. 0.92

    Autobiographical Memory Fluency Reductions in Cognitively Unimpaired Middle-Aged and Older Adults at Increased Risk for Alzheimer's Disease Dementia

    Grilli MD, Wank AA, Huentelman MJ et al. · Journal of the International Neuropsychological Society : JINS · 2021

  36. 0.92

    Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension

    Hajjar I, Sorond F, Lipsitz LA · Journal of the American Geriatrics Society · 2015

  37. 0.92

    Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study

    Whitson HE, Potter GG, Feld JA et al. · Journal of Alzheimer's disease : JAD · 2018

  38. 0.92

    Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study

    Zou H, Luo S, Liu H et al. · The journal of prevention of Alzheimer's disease · 2023

  39. 0.92

    Semantic network function captured by word frequency in nondemented APOE epsilon4 carriers

    Vonk JMJ, Flores RJ, Rosado D et al. · Neuropsychology · 2019

  40. 0.92

    Lack of effect of the apolipoprotein E epsilon4 genotype on cognition during healthy aging

    Knight RG, Tsui HSL, Abraham WC et al. · Journal of clinical and experimental neuropsychology · 2014

  41. 0.92

    Relationships between hourly cognitive variability and risk of Alzheimer's disease revealed with mixed-effects location scale models

    Aschenbrenner AJ, Hassenstab J, Morris JC et al. · Neuropsychology · 2024

  42. 0.91

    Association between Thyroid Hormones, Apolipoprotein E, and Cognitive Function among Cognitively-Normal Elderly Dwellers

    Kim B, Moon SW · Psychiatry investigation · 2020

  43. 0.91

    Memory precision of object-location binding is unimpaired in APOE epsilon4-carriers with spatial navigation deficits

    Gellersen HM, Coughlan G, Hornberger M et al. · Brain communications · 2021

  44. 0.91

    Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory Study

    Welsh-Bohmer KA, Ostbye T, Sanders L et al. · The Clinical neuropsychologist · 2009

  45. 0.91

    Strategy or symptom: Semantic clustering and risk of Alzheimer's disease-related impairment

    Ford J, Zheng B, Hurtado B et al. · Journal of clinical and experimental neuropsychology · 2020

  46. 0.91

    Influence of Alzheimer disease family history and genetic risk on cognitive performance in healthy middle-aged and older people

    Donix M, Ercoli LM, Siddarth P et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2012

  47. 0.91

    A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes

    Caselli RJ, Reiman EM, Hentz JG et al. · Sleep · 2002

  48. 0.91

    Predictors of Heterogeneity in Cognitive Function: APOE-e4, Sex, Education, Depression, and Vascular Risk

    MacAulay RK, Halpin A, Cohen AS et al. · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2020

  49. 0.91

    Abeta-related memory decline in APOE epsilon4 noncarriers: Implications for Alzheimer disease

    Lim YY, Laws SM, Villemagne VL et al. · Neurology · 2016

  50. 0.91

    Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment

    Caselli RJ, Reiman EM, Locke DEC et al. · Archives of neurology · 2007

  51. 0.91

    Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease

    Bondi MW, Salmon DP, Galasko D et al. · Psychology and aging · 1999

  52. 0.90

    Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers

    Stonnington CM, Snyder PJ, Hentz JG et al. · The Journal of clinical psychiatry · 2009

  53. 0.90

    Apolipoprotein E and Its Association With Cognitive Change and Modification of Treatment Effects of Vitamin D3 and Omega-3s on Cognitive Change: Results From the In-Clinic Subset of a Randomized Clinical Trial

    Vyas CM, Kang JH, Mischoulon D et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2024

  54. 0.90

    Social support may buffer the effect of APOE epsilon4 allele on cognition in older adults

    Payen A, Bateman JR, Dhanavanthri Muralidhara S et al. · Journal of Alzheimer's disease : JAD · 2024

  55. 0.90

    The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults

    Laczo J, Cechova K, Parizkova M et al. · Journal of Alzheimer's disease : JAD · 2020

  56. 0.90

    Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner

    Gardener SL, Rainey-Smith SR, Sohrabi HR et al. · Journal of Alzheimer's disease : JAD · 2017

  57. 0.90

    Evidence for Reduced Autobiographical Memory Episodic Specificity in Cognitively Normal Middle-Aged and Older Individuals at Increased Risk for Alzheimer's Disease Dementia

    Grilli MD, Wank AA, Bercel JJ et al. · Journal of the International Neuropsychological Society : JINS · 2018

  58. 0.90

    Combined genetic influences on episodic memory decline in older adults without dementia

    Laukka EJ, Kohncke Y, Papenberg G et al. · Neuropsychology · 2020

  59. 0.90

    Anxiety affects cognition differently in healthy apolipoprotein E epsilon4 homozygotes and non-carriers

    Stonnington CM, Locke DEC, Dueck AC et al. · The Journal of neuropsychiatry and clinical neurosciences · 2011

  60. 0.90

    The relationship between napping and memory varies as a function of genetic risk for Alzheimer's disease

    Faucher C, Thienel R, Behler A et al. · Journal of Alzheimer's disease : JAD · 2026

  61. 0.90

    APOE epsilon4 moderates amyloid-related memory decline in preclinical Alzheimer's disease

    Lim YY, Villemagne VL, Pietrzak RH et al. · Neurobiology of aging · 2015

  62. 0.90

    The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults

    O'Hara R, Yesavage JA, Kraemer HC et al. · Journal of the American Geriatrics Society · 1998

  63. 0.90

    Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults

    de Frias CM, Bunce D, Wahlin A et al. · The journals of gerontology. Series B, Psychological sciences and social sciences · 2007

  64. 0.90

    Association of APOE epsilon4 Status With Long-term Declines in Odor Sensitivity, Odor Identification, and Cognition in Older US Adults

    GoodSmith MS, Wroblewski KE, Schumm LP et al. · Neurology · 2023

  65. 0.90

    Neighborhood psychosocial environment, apolipoprotein E genotype, and cognitive function in older adults

    Lee BK, Glass TA, James BD et al. · Archives of general psychiatry · 2011

  66. 0.89

    Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots

    Adamson MM, Landy KM, Duong S et al. · Neurobiology of aging · 2010

  67. 0.89

    Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele

    Small GW, Chen ST, Komo S et al. · The American journal of psychiatry · 1999

  68. 0.89

    Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders

    Elverman KH, Paitel ER, Figueroa CM et al. · Journal of Alzheimer's disease : JAD · 2021

  69. 0.89

    Association between ApoE epsilon4 genotype and attentional function in non-demented, middle-aged, and older adults from rural India

    Rai P, Sundarakumar JS, Basavaraju N et al. · Journal of neurosciences in rural practice · 2024

  70. 0.89

    Cardiovascular risk factors and APOE-epsilon4 status affect memory functioning in aging via changes to temporal stem diffusion

    McKinnon AC, Stickel A, Ryan L · Journal of neuroscience research · 2021

  71. 0.89

    Body Circumference and Cognitive Function: Role of Apolipoprotein E epsilon4 in the Elderly

    Kim JH, Choe YM, Choi HJ et al. · International journal of molecular sciences · 2025

  72. 0.89

    Habitual dietary nitrate intake and cognition in the Australian Imaging, Biomarkers and Lifestyle Study of ageing: A prospective cohort study

    Rajendra A, Bondonno NP, Murray K et al. · Clinical nutrition (Edinburgh, Scotland) · 2023

  73. 0.89

    The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age

    Ferencz B, Laukka EJ, Lovden M et al. · Frontiers in human neuroscience · 2013

  74. 0.89

    Naturalistic assessment of reaction time variability in older adults at risk for Alzheimer's disease

    Welhaf MS, Wilks H, Aschenbrenner AJ et al. · Journal of the International Neuropsychological Society : JINS · 2024

  75. 0.89

    The Neurocognitive Study for the Aging: Longitudinal Analysis on the Contribution of Sex, Age, Education and APOE varepsilon4 on Cognitive Performance

    Chadjikyprianou A, Hadjivassiliou M, Papacostas S et al. · Frontiers in genetics · 2021

  76. 0.89

    Predictors of cognitive aging profiles over 15 years: A longitudinal population-based study

    Ekstrom I, Josefsson M, Backman L et al. · Psychology and aging · 2024

  77. 0.89

    APOE influences working memory in non-demented elderly through an interaction with SPON1 rs2618516

    Liu Z, Dai X, Tao W et al. · Human brain mapping · 2018

  78. 0.88

    Association between physical activity and episodic memory and the moderating effects of the apolipoprotein E epsilon4 allele and age

    Lee BC, Choe YM, Suh GH et al. · Frontiers in aging neuroscience · 2023

  79. 0.88

    Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults

    Pomara N, Willoughby L, Wesnes K et al. · Archives of general psychiatry · 2005

  80. 0.88

    APOE genotype modifies the association between central arterial stiffening and cognition in older adults

    Cambronero FE, Liu D, Neal JE et al. · Neurobiology of aging · 2018

  81. 0.88

    ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults

    Handley OJ, Morrison CM, Miles C et al. · Neurobiology of aging · 2006

  82. 0.88

    Subtle visuomotor difficulties in preclinical Alzheimer's disease

    Mollica MA, Navarra J, Fernandez-Prieto I et al. · Journal of neuropsychology · 2017

  83. 0.88

    Apolipoprotein E and Clusterin can magnify effects of personality vulnerability on declarative memory performance in non-demented older adults

    Sapkota S, Wiebe SA, Small BJ et al. · International journal of geriatric psychiatry · 2016

  84. 0.88

    History of sexual assault is associated with greater declines in executive functioning in older adults with APOE epsilon4

    Petkus AJ, Wetherell JL, Stein MB et al. · The journals of gerontology. Series B, Psychological sciences and social sciences · 2012

  85. 0.88

    Age-related differences in memory and executive functions in healthy APOE varepsilon4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure

    Bender AR, Raz N · Neuropsychologia · 2012

  86. 0.88

    fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease

    Bondi MW, Houston WS, Eyler LT et al. · Neurology · 2005

  87. 0.88

    APOE moderates compensatory recruitment of neuronal resources during working memory processing in healthy older adults

    Scheller E, Peter J, Schumacher LV et al. · Neurobiology of aging · 2017

  88. 0.87

    Problems meeting basic needs moderate the association between the APOE epsilon4 allele and cognitive decline

    Sachs-Ericsson N, Corsentino E, Collins N et al. · Aging & mental health · 2010

  89. 0.87

    Childhood socioeconomic status and genetic risk for poorer cognition in later life

    Moorman SM, Carr K, Greenfield EA · Social science & medicine (1982) · 2018

  90. 0.87

    Association of non-exercise physical activity in mid- and late-life with cognitive trajectories and the impact of APOE epsilon4 genotype status: the Mayo Clinic Study of Aging

    Krell-Roesch J, Syrjanen JA, Vassilaki M et al. · European journal of ageing · 2019

  91. 0.87

    Spouse-Appraised Memory Functioning Predicts Memory Decline Better Than Subjective Memory Complaints in Community Dwelling Older Adults at Genetic Risk for Alzheimer's Disease

    Bellaali Y, Woodard JL, Hanseeuw B et al. · Frontiers in psychiatry · 2021

  92. 0.87

    The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes

    Ravona-Springer R, Heymann A, Schmeidler J et al. · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2014

  93. 0.87

    SPON1 Is Associated with Amyloid-beta and APOE epsilon4-Related Cognitive Decline in Cognitively Normal Adults

    Fernandez S, Burnham SC, Milicic L et al. · Journal of Alzheimer's disease reports · 2021

  94. 0.86

    Kinematic correlates of early speech motor changes in cognitively intact APOE-epsilon4 carriers: a preliminary study using a color-word interference task

    Dadgostar M, Hanford LC, Green JR et al. · Frontiers in neurology · 2025

  95. 0.86

    APOE genotype and cognitive change in young, middle-aged, and older adults living in the community

    Bunce D, Bielak AAM, Anstey KJ et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2014

  96. 0.86

    Decline in cognitive function over 18 months in healthy older adults with high amyloid-beta

    Ellis KA, Lim YY, Harrington K et al. · Journal of Alzheimer's disease : JAD · 2013

  97. 0.86

    Impact of sex and APOE epsilon4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults

    Petersen KK, Grober E, Lipton RB et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022

  98. 0.86

    The relation of ApoE and COMT gene-gene interactions to cognitive and motor function in community-dwelling older adults: a pilot study

    Pizzonia KL, Suhr JA, Clark LA et al. · Frontiers in aging neuroscience · 2023

  99. 0.86

    Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals

    Olofsson JK, Larsson M, Roa C et al. · Behavior genetics · 2020

  100. 0.86

    Apolipoprotein E genotype does not moderate the associations of depressive symptoms, neuroticism and allostatic load with cognitive ability and cognitive aging in the Lothian Birth Cohort 1936

    Crook Z, Booth T, Cox SR et al. · PloS one · 2018

  101. 0.85

    Visual Memory Deficits in Middle-Aged APOEvarepsilon4 Homozygotes Detected Using Unsupervised Cognitive Assessments

    Lim YY, Pase MP, Buckley RF et al. · Journal of Alzheimer's disease : JAD · 2021

  102. 0.85

    Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population

    Thibeau S, McFall GP, Camicioli R et al. · Journal of Alzheimer's disease : JAD · 2017

  103. 0.85

    Perivascular space burden interacts with APOE-epsilon4 status on cognition in older adults

    Gogniat MA, Khan OA, Bown CW et al. · Neurobiology of aging · 2024

  104. 0.85

    Apolipoprotein E Genotype Modifies the Association Between Cardiac Output and Cognition in Older Adults

    Bown CW, Liu D, Osborn KE et al. · Journal of the American Heart Association · 2019

  105. 0.85

    Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease

    Stonnington CM, Harel B, Locke DEC et al. · Alzheimer disease and associated disorders · 2017

  106. 0.85

    A Multimodal Risk Network Predicts Executive Function Trajectories in Non-demented Aging

    Sapkota S, McFall GP, Masellis M et al. · Frontiers in aging neuroscience · 2021

  107. 0.85

    Protein intake and episodic memory: the moderating role of the apolipoprotein E epsilon4 status

    Keum M, Lee BC, Choe YM et al. · Alzheimer's research & therapy · 2024

  108. 0.85

    Moderate alcohol use and apolipoprotein E-4 (ApoE-4): Independent effects on cognitive outcomes in later life

    Herring D, Paulson D · Journal of clinical and experimental neuropsychology · 2018

  109. 0.85

    APOE epsilon4 Modulation of Training Outcomes in Several Cognitive Domains in a Sample of Cognitively Intact Older Adults

    Lopez-Higes R, Rodriguez-Rojo IC, Prados JM et al. · Journal of Alzheimer's disease : JAD · 2017

  110. 0.85

    Variations in the APOE allele or BDNF Val66Met polymorphism are not associated with changes in cognitive function following a tertiary education intervention in older adults: the Tasmanian Healthy Brain Project

    Thow ME, Summers MJ, Summers JJ et al. · Neurobiology of aging · 2017

  111. 0.84

    Genetic Risk for Alzheimer's Disease Alters Perceived Executive Dysfunction in Cognitively Healthy Middle-Aged and Older Adults

    Evans SA, Paitel ER, Bhasin R et al. · Journal of Alzheimer's disease reports · 2024

  112. 0.84

    Manganese level and cognitive decline in older adults with the APOE e4 allele: a preliminary study

    Kim SG, Choe YM, Suh GH et al. · Psychiatry research · 2023

  113. 0.84

    Associations Between the Apnea-Hypopnea Index During REM and NREM Sleep and Cognitive Functioning in a Cohort of Middle-Aged Adults

    Devita M, Peppard PE, Mesas AE et al. · Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2019

  114. 0.84

    Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older

    Bunce D, Kivipelto M, Wahlin A · Neuropsychology · 2004

  115. 0.84

    Brain health registry GenePool study: A novel approach to online genetics research

    Fockler J, Kwang W, Ashford MT et al. · Alzheimer's & dementia (New York, N. Y.) · 2021

  116. 0.84

    Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

    Soldevila-Domenech N, Fagundo B, Cuenca-Royo A et al. · Nutrition journal · 2024

  117. 0.84

    Cerebellar EEG source localization reveals age-related compensatory activity moderated by genetic risk for Alzheimer's disease

    Paitel ER, Nielson KA · Psychophysiology · 2023

  118. 0.84

    ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among epsilon2 carriers

    McFall GP, Wiebe SA, Vergote D et al. · Neuropsychology · 2015

  119. 0.83

    Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults

    Lineweaver TT, Bondi MW, Galasko D et al. · The American journal of psychiatry · 2014

  120. 0.83

    Blood pressure interacts with APOE epsilon4 to predict memory performance in a midlife sample

    Oberlin LE, Manuck SB, Gianaros PJ et al. · Neuropsychology · 2015

  121. 0.83

    Life experience and demographic influences on cognitive function in older adults

    Brewster PWH, Melrose RJ, Marquine MJ et al. · Neuropsychology · 2014

  122. 0.83

    Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers

    O'Hara R, Schroder CM, Kraemer HC et al. · Neurology · 2005

  123. 0.83

    Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer's genetic risk

    Thibeau S, McDermott K, McFall GP et al. · Alzheimer's research & therapy · 2019

  124. 0.83

    Lower Cardiac Output Relates to Longitudinal Cognitive Decline in Aging Adults

    Bown CW, Do R, Khan OA et al. · Frontiers in psychology · 2020

  125. 0.82

    Dopamine Receptor Genes Modulate Associative Memory in Old Age

    Papenberg G, Becker N, Ferencz B et al. · Journal of cognitive neuroscience · 2017

  126. 0.82

    Remote assessments of sleep and cognition in cognitively normal older adults at risk for Alzheimer disease

    Wilks HM, Welhaf MS, Aschenbrenner AJ et al. · Sleep medicine · 2026

  127. 0.82

    High Glycemic Load Is Associated with Cognitive Decline in Apolipoprotein E epsilon4 Allele Carriers

    Gentreau M, Raymond M, Chuy V et al. · Nutrients · 2020

  128. 0.82

    Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly

    Dhilla Albers A, Asafu-Adjei J, Delaney MK et al. · Annals of neurology · 2016

  129. 0.82

    Selenium and Episodic Memory: The Moderating Role of Apolipoprotein E epsilon4

    Kim SG, Keum M, Choe YM et al. · Nutrients · 2025

  130. 0.82

    Comparison of semantic and episodic memory BOLD fMRI activation in predicting cognitive decline in older adults

    Hantke N, Nielson KA, Woodard JL et al. · Journal of the International Neuropsychological Society : JINS · 2013

  131. 0.81

    A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease

    Porter T, Burnham SC, Savage G et al. · Frontiers in aging neuroscience · 2018

  132. 0.81

    Depression, cognition, apolipoprotein e genotype: latent class approach to identifying subtype

    Bogner HR, Richie MB, de Vries HF et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2009

  133. 0.80

    The associations of the BDNF and APOE polymorphisms, hippocampal subfield volumes, and episodic memory performance across the lifespan

    Malykhin NV, Travis S, Fujiwara E et al. · Hippocampus · 2020

  134. 0.80

    Apolipoprotein E epsilon4 allele impairs cortical activity in healthy aging and Alzheimer's disease

    Pedroso RV, Fraga FJ, Nascimento CMC et al. · Behavioural brain research · 2022

  135. 0.80

    Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults

    Schaeverbeke JM, Gabel S, Meersmans K et al. · Alzheimer's research & therapy · 2021

  136. 0.80

    Associations of APOE epsilon4 With Health and Financial Literacy Among Community-Based Older Adults Without Dementia

    Stewart CC, Boyle PA, James BD et al. · The journals of gerontology. Series B, Psychological sciences and social sciences · 2018

  137. 0.80

    APOE epsilon4 genotype predicts memory for everyday activities

    Bailey HR, Sargent JQ, Flores S et al. · Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2015

  138. 0.79

    Adiposity measures predict olfactory processing speed in older adult carriers of the apolipoprotein E epsilon4 allele

    Zamora R, Bartholow J, Green E et al. · Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2012

  139. 0.79

    Association between subjective memory assessment and associative memory performance: Role of ad risk factors

    Horn MM, Kennedy KM, Rodrigue KM · Psychology and aging · 2018

  140. 0.79

    Examination of race and gender differences in predictors of neuropsychological decline and development of Alzheimer's disease

    Johnson EEH, Alexander C, Lee GJ et al. · The Clinical neuropsychologist · 2022

  141. 0.79

    Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults

    Walters S, Contreras AG, Eissman JM et al. · JAMA neurology · 2023

  142. 0.79

    Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia

    Mehta K, Mohebbi M, Pasco JA et al. · Scientific reports · 2022

  143. 0.78

    Association of enlarged perivascular spaces with cognitive function in dementia-free older adults: A population-based study

    Zhao M, Li Y, Han X et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  144. 0.78

    Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study

    Pike KE, Ellis KA, Villemagne VL et al. · Neuropsychologia · 2011

  145. 0.78

    Latent Classes of Cognitive Functioning Among Depressed Older Adults Without Dementia

    Morin RT, Insel P, Nelson C et al. · Journal of the International Neuropsychological Society : JINS · 2019

  146. 0.77

    COMT val158met is not associated with Abeta-amyloid and APOE epsilon4 related cognitive decline in cognitively normal older adults

    Porter T, Burnham SC, Milicic L et al. · IBRO reports · 2019

  147. 0.77

    Dietary Patterns and Cognitive Decline in Older Adults: Findings from the Western Australia Memory Study

    Blagojevic Castro C, Gardener SL, Jahan F et al. · Nutrients · 2026

  148. 0.77

    Cardiovascular Risk Associated with Poorer Memory in Middle-Aged Adults from the Healthy Brain Project

    Yassi N, Pase MP, Buckley RF et al. · Journal of Alzheimer's disease : JAD · 2022

  149. 0.77

    Low testosterone levels relate to poorer cognitive function in women in an APOE-epsilon4-dependant manner

    Dratva MA, Banks SJ, Panizzon MS et al. · Biology of sex differences · 2024

  150. 0.76

    Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance

    Dowling NM, Gleason CE, Manson JE et al. · PloS one · 2013

  151. 0.75

    Current versus lifetime depression, APOE variation, and their interaction on cognitive performance in younger and older adults

    Luciano M, Pujals AMF, Marioni RE et al. · Psychosomatic medicine · 2015

  152. 0.75

    Apoe genotype knowledge and its impact on cognitive beliefs and performance

    Barber SJ, Menon M, Shoemaker KJ et al. · Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2026

  153. 0.75

    Older adults at greater risk for Alzheimer's disease show stronger associations between sleep apnea severity in REM sleep and verbal memory

    Lui KK, Dave A, Sprecher KE et al. · Alzheimer's research & therapy · 2024

  154. 0.74

    Older adults at greater risk for Alzheimer's disease show stronger associations between sleep apnea severity and verbal memory

    Lui K, Dave A, Sprecher K et al. · Research square · 2023

  155. 0.74

    Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status

    Wu CY, Ouk M, Wong YY et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020

  156. 0.74

    Sex Difference in the Association of APOE4 with Memory Decline in Mild Cognitive Impairment

    Wang X, Zhou W, Ye T et al. · Journal of Alzheimer's disease : JAD · 2019

  157. 0.74

    Olfactory ERPs in an odor/visual congruency task differentiate ApoE epsilon4 carriers from non-carriers

    Kowalewski J, Murphy C · Brain research · 2012

  158. 0.74

    APOE Genotype-Stratified Meta-Analysis of Cognitive Decline Reveals Novel Loci for Language and Global Cognitive Function in Older Adults

    Acharya V, Fan KH, Snitz BE et al. · International journal of molecular sciences · 2025

  159. 0.73

    Influences of APOE epsilon4 and expertise on performance of older pilots

    Taylor JL, Kennedy Q, Adamson MM et al. · Psychology and aging · 2011

  160. 0.73

    Trajectories and timing of accelerated decline in specific memory domains preceding Alzheimer's disease

    Long X, Rong M, Long S et al. · Frontiers in aging neuroscience · 2026

  161. 0.72

    Profiles of cognitive functioning in a population-based sample of centenarians using factor mixture analysis

    Davey A, Dai T, Woodard JL et al. · Experimental aging research · 2013

  162. 0.71

    Association Between Menopause Age and Estradiol-Based Hormone Therapy With Cognitive Performance in Cognitively Normal Women in the CLSA

    Puri TA, Gravelsins LL, Alexander MW et al. · Neurology · 2025

  163. 0.71

    Remote Identification of APOE-epsilon4 Carrier Status in Cognitively Normal Adults via Speech Acoustics: Cross-Sectional Observational Study

    Tavakoli M, Dadgostar M, Green JR et al. · JMIR formative research · 2026

  164. 0.70

    Increased sedentary behavior is associated with neurodegeneration and worse cognition in older adults over a 7-year period despite high levels of physical activity

    Gogniat MA, Khan OA, Li J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  165. 0.69

    Dataset on the associations between sleep quality/duration and cognitive performance in cognitively healthy older adults

    Tsapanou A, Gu Y, O'Shea DM et al. · Data in brief · 2017

  166. 0.68

    APOE-epsilon4 is associated with memory decline in cognitively impaired elderly

    Dik MG, Jonker C, Bouter LM et al. · Neurology · 2000

  167. 0.66

    Apolipoprotein varepsilon4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics

    Oviedo DC, Perez-Lao AR, Flores-Cuadra JA et al. · Journal of Alzheimer's disease : JAD · 2021

  168. 0.66

    Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals

    Hulette CM, Welsh-Bohmer KA, Murray MG et al. · Journal of neuropathology and experimental neurology · 1998

  169. 0.66

    Influence of APOE Genotype on Mortality and Cognitive Impairment

    Robinson AC, Davidson YS, Roncaroli F et al. · Journal of Alzheimer's disease reports · 2020

  170. 0.66

    Analysis of cognitive performance and polymorphisms of SORL1, PVRL2, CR1, TOMM40, APOE, PICALM, GWAS_14q, CLU, and BIN1 in patients with mild cognitive impairment and cognitively healthy controls

    Cruz-Sanabria F, Bonilla-Vargas K, Estrada K et al. · Neurologia · 2021

  171. 0.65

    Demographic-Adjusted Normative Equations for the Oculo-Cognitive Addition Test (OCAT): A Foundation for Individualized Oculo-Cognitive Assessment

    Pradhan GN, Kingsbury SE, Stepanek J et al. · Journal of eye movement research · 2026

  172. 0.65

    APOEepsilon4 and slow wave sleep in older adults

    Tranah GJ, Yaffe K, Nievergelt CM et al. · PloS one · 2018

  173. 0.64

    Temporal contiguity and ageing: The role of memory organization in cognitive decline

    Talamonti D, Koscik R, Johnson S et al. · Journal of neuropsychology · 2021

  174. 0.64

    Apolipoprotein E, Executive Function, and Falls across Cognitive Status: A Cross-Sectional Study

    Delgado F, Yu F, Peterson DS et al. · Dementia and geriatric cognitive disorders · 2026

  175. 0.63

    Interaction between Alcohol Consumption and Apolipoprotein E (ApoE) Genotype with Cognition in Middle-Aged Men

    Slayday RE, Gustavson DE, Elman JA et al. · Journal of the International Neuropsychological Society : JINS · 2021

  176. 0.63

    Testing influences of APOE and BDNF genes and heart failure on cognitive function

    Jung M, Apostolova LG, Gao S et al. · Heart & lung : the journal of critical care · 2021

  177. 0.62

    Joint trajectories of episodic memory and odor identification in older adults: patterns and predictors

    Dintica CS, Haaksma ML, Olofsson JK et al. · Aging · 2021

  178. 0.61

    Predicting Alzheimer's disease with practice effects, APOE genotype and brain metabolism

    Oltra-Cucarella J, Sanchez-SanSegundo M, Ferrer-Cascales R · Neurobiology of aging · 2022

  179. 0.61

    Modifiable Lifestyle Activities Affect Cognition in Cognitively Healthy Middle-Aged Individuals at Risk for Late-Life Alzheimer's Disease

    Heneghan A, Deng F, Wells K et al. · Journal of Alzheimer's disease : JAD · 2023

  180. 0.60

    Recall and recognition subtests of the repeatable battery for the assessment of neuropsychological status and their relationship to biomarkers of Alzheimer's disease

    Euler MJ, Duff K, King JB et al. · Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2023

  181. 0.60

    Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease

    Oviedo DC, Lezcano H, Perez AR et al. · AIMS neuroscience · 2018

  182. 0.58

    Practice Effect of Repeated Cognitive Tests Among Older Adults: Associations With Brain Amyloid Pathology and Other Influencing Factors

    Zheng B, Udeh-Momoh C, Watermeyer T et al. · Frontiers in aging neuroscience · 2022

  183. 0.58

    Association Between Traumatic Brain Injury and Cognitive Decline Among Middle-to-Older Aged Men in the Vietnam Era Twin Study of Aging

    Posis AIB, Alcaraz JE, Parada HJ et al. · Neurotrauma reports · 2024

  184. 0.57

    Association of obstructive sleep apnea with cognitive decline and age among non-demented older adults

    Pan T, Liu S, Ke S et al. · Neuroscience letters · 2021

  185. 0.57

    Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration

    Pomara N, Facelle TM, Roth AE et al. · Psychopharmacology · 2006

  186. 0.57

    Interleukin 10 (IL10) promoter region polymorphism is associated with IL10 serum concentrations and processing speed in healthy community-dwelling older adults

    Keegan AP, Savage K, Bousman CA et al. · Behavioural brain research · 2024

  187. 0.55

    Phishing vulnerability compounded by older age, apolipoprotein E e4 genotype, and lower cognition

    Pehlivanoglu D, Shoenfelt A, Hakim Z et al. · PNAS nexus · 2024

  188. 0.54

    Depression Trajectories, Genetic Risk, and Cognitive Performance in Older Adults: Multilevel Model with a 10-Year Longitudinal Cohort

    Liu Z, Su Y, Huang R et al. · Gerontology · 2023

  189. 0.54

    Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression

    Bangen KJ, Delano-Wood L, Wierenga CE et al. · International journal of geriatric psychiatry · 2010

  190. 0.52

    Sex differences in the association between episodic memory residual reserve index and change in executive function

    Chooi C, Gavett BE, Ames D et al. · Aging brain · 2025

  191. 0.51

    Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease

    Watson GS, Baker LD, Cholerton BA et al. · Journal of Alzheimer's disease : JAD · 2009

  192. 0.51

    Neuropsychological measures in normal individuals that predict subsequent cognitive decline

    Blacker D, Lee H, Muzikansky A et al. · Archives of neurology · 2007

  193. 0.50

    Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults

    Abdelmessih GT, Bransby L, Cummins H et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  194. 0.50

    Apolipoprotein E genotype and cognitive impairment in community-dwelling black older adults

    Harwood DG, Barker WW, Ownby RL et al. · International journal of psychiatry in medicine · 2002

02brain · magnetic resonance159편

  1. 0.95

    Age-related differences in white matter integrity and cognitive function are related to APOE status

    Ryan L, Walther K, Bendlin BB et al. · NeuroImage · 2011

  2. 0.95

    APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults

    Hays CC, Zlatar ZZ, Meloy MJ et al. · NeuroImage · 2019

  3. 0.93

    Higher Brain Perfusion May Not Support Memory Functions in Cognitively Normal Carriers of the ApoE epsilon4 Allele Compared to Non-Carriers

    Zlatar ZZ, Bischoff-Grethe A, Hays CC et al. · Frontiers in aging neuroscience · 2016

  4. 0.93

    Impact of APOE-epsilon alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study

    Lacey C, Paterson T, Gawryluk JR · PloS one · 2024

  5. 0.93

    Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study

    Honea RA, Vidoni E, Harsha A et al. · Journal of Alzheimer's disease : JAD · 2009

  6. 0.93

    Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks

    Didic M, Felician O, Gour N et al. · European journal of nuclear medicine and molecular imaging · 2015

  7. 0.93

    Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline

    Hays CC, Zlatar ZZ, Meloy MJ et al. · Brain imaging and behavior · 2020

  8. 0.93

    Hippocampal connectivity and memory decline in cognitively intact APOE epsilon4 carriers

    Baxter LC, Limback-Stokin M, Patten KJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  9. 0.92

    APOE Genotype Modifies the Association of Fusiform Gyrus Cerebral Metabolic Rate of Oxygen Consumption and Object Naming Performance

    Hays Weeks CC, Zlatar ZZ, Meloy MJ et al. · Journal of Alzheimer's disease : JAD · 2023

  10. 0.92

    Functional segregation loss over time is moderated by APOE genotype in healthy elderly

    Ng KK, Qiu Y, Lo JCY et al. · Human brain mapping · 2018

  11. 0.92

    Regulating effect of CBF on memory in cognitively normal older adults with different ApoE genotype: the Alzheimer's Disease Neuroimaging Initiative (ADNI)

    Wang J, Peng G, Liu P et al. · Cognitive neurodynamics · 2019

  12. 0.92

    Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults

    Jak AJ, Houston WS, Nagel BJ et al. · Dementia and geriatric cognitive disorders · 2007

  13. 0.92

    Genotypic effects of APOE-epsilon4 on resting-state connectivity in cognitively intact individuals support functional brain compensation

    Cacciaglia R, Operto G, Falcon C et al. · Cerebral cortex (New York, N.Y. : 1991) · 2023

  14. 0.92

    Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease

    Wierenga CE, Stricker NH, McCauley A et al. · NeuroImage · 2010

  15. 0.91

    Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers

    Kukolja J, Thiel CM, Eggermann T et al. · Neuroscience · 2010

  16. 0.91

    Familiarity deficits in cognitively normal aging individuals with APOE epsilon4: A follow-up investigation of medial temporal lobe structural correlates

    Schoemaker D, Poirier J, Collins DL et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2017

  17. 0.91

    Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume

    Striepens N, Scheef L, Wind A et al. · Psychological medicine · 2011

  18. 0.91

    Longitudinal effects of cerebrovascular reactivity and cerebral pulsatility in cognitively intact older adults with APOE4: links with cognition

    Potvin-Jutras Z, Tremblay PL, Mohammadi H et al. · GeroScience · 2026

  19. 0.91

    Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders

    Rao SM, Bonner-Jackson A, Nielson KA et al. · NeuroImage · 2015

  20. 0.91

    Impact of age and apolipoprotein E epsilon4 status on regional white matter hyperintensity volume and cognition in healthy aging

    Van Etten EJ, Bharadwaj PK, Grilli MD et al. · Journal of the International Neuropsychological Society : JINS · 2024

  21. 0.90

    The selective vulnerability of the left fimbria in cognitively normal APOE epsilon4 carriers: a localized structural correlate of high genetic risk for Alzheimer's disease

    Suo Y, Wang L, Zhao Y et al. · Behavioural brain research · 2026

  22. 0.90

    Differential 5-year brain atrophy rates in cognitively declining and stable APOE-epsilon4 elders

    Kelly DA, Seidenberg M, Reiter K et al. · Neuropsychology · 2018

  23. 0.90

    Obesity reduces hippocampal structure and function in older African Americans with the APOE-epsilon4 Alzheimer's disease risk allele

    Osiecka Z, Fausto BA, Gills JL et al. · Frontiers in aging neuroscience · 2023

  24. 0.90

    APOE4 allele-specific associations between diet, multimodal biomarkers, and cognition among Puerto Rican adults in Massachusetts

    Guan Y, Cheng CH, Bellomo LI et al. · Frontiers in aging neuroscience · 2023

  25. 0.90

    Apolipoprotein E epsilon4 Allele-Based Differences in Brain Volumes Are Largely Uniform Across Late Middle Aged and Older Hispanic/Latino- and Non-Hispanic/Latino Whites Without Dementia

    Stickel AM, McKinnon AC, Matijevic S et al. · Frontiers in aging neuroscience · 2021

  26. 0.88

    The Specific Impact of Apolipoprotein E Epsilon 2 on Cognition and Brain Function in Cognitively Normal Elders and Mild Cognitive Impairment Patients

    Gong L, Xu R, Liu D et al. · Frontiers in aging neuroscience · 2019

  27. 0.88

    Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local beta-amyloid, Tau, and APOE4

    Quevenco FC, van Bergen JM, Treyer V et al. · Frontiers in aging neuroscience · 2020

  28. 0.88

    Lifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy aging

    Woodard JL, Sugarman MA, Nielson KA et al. · Current Alzheimer research · 2012

  29. 0.88

    Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer's disease

    Vereb D, Mijalkov M, Chang YW et al. · Alzheimer's research & therapy · 2023

  30. 0.88

    Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status

    Reas ET, Triebswetter C, Banks SJ et al. · Alzheimer's research & therapy · 2024

  31. 0.88

    Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults

    Fischer L, Adams JN, Molloy EN et al. · Alzheimer's research & therapy · 2025

  32. 0.87

    Brain Aging and APOE epsilon4 Interact to Reveal Potential Neuronal Compensation in Healthy Older Adults

    Scheller E, Schumacher LV, Peter J et al. · Frontiers in aging neuroscience · 2018

  33. 0.86

    Associations between Education Years and Resting-state Functional Connectivity Modulated by APOE epsilon4 Carrier Status in Cognitively Normal Older Adults

    Kim J, Kim S, Um YH et al. · Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024

  34. 0.86

    Apolipoprotein E epsilon4 accelerates the longitudinal cerebral atrophy in open access series of imaging studies-3 elders without dementia at enrollment

    Huang Y, Shan Y, Qin W et al. · Frontiers in aging neuroscience · 2023

  35. 0.85

    Peripheral apoE isoform levels in cognitively normal APOE epsilon3/epsilon4 individuals are associated with regional gray matter volume and cerebral glucose metabolism

    Nielsen HM, Chen K, Lee W et al. · Alzheimer's research & therapy · 2017

  36. 0.85

    Inhibitory P300 subprocesses and neural compensation in genetic risk for Alzheimer's disease: The case for temporal-spatial principal component analysis

    Paitel ER, Nielson KA · Psychophysiology · 2024

  37. 0.85

    Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults

    Li J, Mountz EJ, Mizuno A et al. · Journal of Alzheimer's disease : JAD · 2023

  38. 0.84

    Differences in resting state functional connectivity underlie visuomotor performance declines in older adults with a genetic risk (APOE epsilon4) for Alzheimer's disease

    Rogojin A, Gorbet DJ, Hawkins KM et al. · Frontiers in aging neuroscience · 2022

  39. 0.84

    Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates

    Chen K, Reiman EM, Alexander GE et al. · The American journal of psychiatry · 2007

  40. 0.84

    A profile of brain reserve in adults at genetic risk of Alzheimer's disease

    Coughlan G, Zhukovsky P, Voineskos A et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  41. 0.84

    Sex-Specific Entorhinal Cortex Functional Connectivity in Cognitively Normal Older Adults with Amyloid-beta Pathology

    Gong L, Liu D, Zhang B et al. · Molecular neurobiology · 2025

  42. 0.84

    RNASE6 is a novel modifier of APOE-epsilon4 effects on cognition

    Seto M, Weiner RL, Dumitrescu L et al. · Neurobiology of aging · 2022

  43. 0.84

    Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE varepsilon4 allele

    Adamson MM, Hutchinson JB, Shelton AL et al. · Neuropsychologia · 2011

  44. 0.83

    Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease

    Reiman EM, Uecker A, Caselli RJ et al. · Annals of neurology · 1998

  45. 0.83

    Prediction of cognitive decline in healthy older adults using fMRI

    Woodard JL, Seidenberg M, Nielson KA et al. · Journal of Alzheimer's disease : JAD · 2010

  46. 0.83

    Asymmetric left-right hippocampal glutamatergic modulation of cognitive control in ApoE-isoform subjects is unrelated to neuroinflammation

    Zhang H, Chiu PW, Ip I et al. · The European journal of neuroscience · 2021

  47. 0.83

    Genetic risk of Alzheimer's disease is associated with loss of brain network segregation in midlife

    Deng F, Henson RN, Muniz-Terrera G et al. · Communications biology · 2026

  48. 0.83

    Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study

    Lu PH, Thompson PM, Leow A et al. · Journal of Alzheimer's disease : JAD · 2011

  49. 0.82

    APOE-epsilon4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals

    Cacciaglia R, Molinuevo JL, Falcon C et al. · NeuroImage. Clinical · 2019

  50. 0.82

    Neuronal fiber bundle lengths in healthy adult carriers of the ApoE4 allele: a quantitative tractography DTI study

    Salminen LE, Schofield PR, Lane EM et al. · Brain imaging and behavior · 2013

  51. 0.82

    Interactive effects of physical activity and APOE-epsilon4 on white matter tract diffusivity in healthy elders

    Smith JC, Lancaster MA, Nielson KA et al. · NeuroImage · 2016

  52. 0.82

    KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE epsilon4-positive cognitively normal adults with high Abeta-amyloid burden

    Porter T, Burnham SC, Dore V et al. · Scientific reports · 2018

  53. 0.82

    Semantic memory activation in individuals at risk for developing Alzheimer disease

    Seidenberg M, Guidotti L, Nielson KA et al. · Neurology · 2009

  54. 0.82

    Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults

    Goveas JS, Xie C, Chen G et al. · PloS one · 2013

  55. 0.82

    Differential Effect of APOE varepsilon4 Status and Elevated Pulse Pressure on Functional Decline in Cognitively Normal Older Adults

    Werhane ML, Thomas KR, Edmonds EC et al. · Journal of Alzheimer's disease : JAD · 2018

  56. 0.81

    The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory

    Xu G, McLaren DG, Ries ML et al. · Brain : a journal of neurology · 2009

  57. 0.80

    DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease

    Sala-Vila A, Arenaza-Urquijo EM, Sanchez-Benavides G et al. · The American journal of clinical nutrition · 2021

  58. 0.80

    Vascular burden and APOE epsilon4 are associated with white matter microstructural decline in cognitively normal older adults

    Williams OA, An Y, Beason-Held L et al. · NeuroImage · 2019

  59. 0.80

    Arterial spin labeling imaging reveals widespread and Abeta-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers

    Michels L, Warnock G, Buck A et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2016

  60. 0.80

    Dendritic spine remodeling accompanies Alzheimer's disease pathology and genetic susceptibility in cognitively normal aging

    Boros BD, Greathouse KM, Gearing M et al. · Neurobiology of aging · 2019

  61. 0.79

    Evidence of APOE4-related brain vulnerabilities in verbal memory systems in midlife women

    Wugalter KA, Thurston RC, Wu M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  62. 0.79

    Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old age

    Schreiner SJ, Van Bergen JMG, Gietl AF et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  63. 0.79

    APOE epsilon4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer's disease

    Coughlan G, Larsen R, Kim M et al. · Brain communications · 2021

  64. 0.78

    Brain activation in older adults during odor identification is related to ApoE, t-tau/Abeta(1-42), and hippocampal volume

    Albertazzi A, Murphy C · Neurobiology of aging · 2025

  65. 0.78

    Differential effects of the APOE genotype on brain function across the lifespan

    Filippini N, Ebmeier KP, MacIntosh BJ et al. · NeuroImage · 2011

  66. 0.78

    Functional Connectivity Change Associated With Apolipoprotein E Allotypes Precedes Structural Connectivity and Neurodegeneration in Cognitive Normal Older Adults Without Cerebral Abeta Deposition

    Wang SM, Kang DW, Um YH et al. · Psychiatry investigation · 2023

  67. 0.78

    Precuneus degeneration in nondemented elderly individuals with APOE varepsilon4: Evidence from structural and functional MRI analyses

    Chen Y, Liu Z, Zhang J et al. · Human brain mapping · 2017

  68. 0.77

    Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer's disease

    Zhang J, Sun L, Yang X et al. · Translational psychiatry · 2026

  69. 0.77

    Associations between differential connectivity patterns of executive control networks and APOE varepsilon4 in the Alzheimer continuum

    Han R, Zhang X, Chen Y et al. · Brain research · 2025

  70. 0.76

    The relationship between physical activity, apolipoprotein E epsilon4 carriage, and brain health

    de Frutos-Lucas J, Cuesta P, Lopez-Sanz D et al. · Alzheimer's research & therapy · 2020

  71. 0.76

    Structural and functional neural correlates of visuospatial information processing in normal aging and amnestic mild cognitive impairment

    Alichniewicz KK, Brunner F, Klunemann HH et al. · Neurobiology of aging · 2012

  72. 0.76

    APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging

    Thambisetty M, Beason-Held L, An Y et al. · Archives of neurology · 2010

  73. 0.76

    Interaction between years of education and APOE epsilon4 status on frontal and temporal metabolism

    Arenaza-Urquijo EM, Gonneaud J, Fouquet M et al. · Neurology · 2015

  74. 0.76

    The Relationship Between Plasma Abeta Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study

    Poljak A, Crawford JD, Smythe GA et al. · Current Alzheimer research · 2016

  75. 0.75

    The Association of APOE epsilon4 Allele with Retinal Layer Thickness and Microvasculature in Older Adults: Optic Nerve Decline and Cognitive Change Study

    Sheriff S, Shen T, Saks D et al. · Journal of clinical medicine · 2023

  76. 0.75

    APOE4 moderates effects of cortical iron on synchronized default mode network activity in cognitively healthy old-aged adults

    Kagerer SM, van Bergen JMG, Li X et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2020

  77. 0.75

    APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset

    Rabipour S, Rajagopal S, Yu E et al. · Journal of Alzheimer's disease : JAD · 2020

  78. 0.75

    Impact of sex and APOE epsilon4 on age-related cerebral perfusion trajectories in cognitively asymptomatic middle-aged and older adults: A longitudinal study

    Wang R, Oh JM, Motovylyak A et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021

  79. 0.75

    Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups

    Fleisher AS, Sherzai A, Taylor C et al. · NeuroImage · 2009

  80. 0.74

    Interactive effects of the APOE and BDNF polymorphisms on functional brain connectivity: the Tasmanian Healthy Brain Project

    Pietzuch M, Bindoff A, Jamadar S et al. · Scientific reports · 2021

  81. 0.74

    A Triple Network Connectivity Study of Large-Scale Brain Systems in Cognitively Normal APOE4 Carriers

    Wu X, Li Q, Yu X et al. · Frontiers in aging neuroscience · 2016

  82. 0.74

    Pulse pressure trajectories predict brain microstructure in community-dwelling older adults: Associations with executive function and modification by APOE

    Parada HJ, Bergstrom J, Bangen KJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  83. 0.73

    Longitudinal excitation-inhibition balance altered by sex and APOE-epsilon4

    Burns AP, Fortel I, Zhan L et al. · Communications biology · 2025

  84. 0.72

    Lower cerebral oxygen utilization is associated with Alzheimer's disease-related neurodegeneration and poorer cognitive performance among apolipoprotein E epsilon4 carriers

    Robb WH, Khan OA, Ahmed HA et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022

  85. 0.72

    Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism

    Lee YG, Park M, Jeong SH et al. · Neurobiology of aging · 2021

  86. 0.71

    Cardiorespiratory fitness mitigates brain atrophy and cognitive decline in adults at risk for Alzheimer's disease

    Dougherty RJ, Jonaitis EM, Gaitan JM et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  87. 0.71

    Surgery is associated with ventricular enlargement as well as cognitive and functional decline

    Schenning KJ, Murchison CF, Mattek NC et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016

  88. 0.71

    Impact of 5-HTTLPR on hippocampal subregional activation in older adults

    Garrett A, Gupta S, Reiss AL et al. · Translational psychiatry · 2015

  89. 0.71

    Regional hyperperfusion in cognitively normal APOE epsilon4 allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohort

    McKiernan EF, Mak E, Dounavi ME et al. · Journal of neurology, neurosurgery, and psychiatry · 2020

  90. 0.70

    Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age

    Zannas AS, McQuoid DR, Payne ME et al. · The American journal of psychiatry · 2014

  91. 0.70

    Imbalanced hippocampal functional networks associated with remitted geriatric depression and apolipoprotein E epsilon4 allele in nondemented elderly: a preliminary study

    Shu H, Yuan Y, Xie C et al. · Journal of affective disorders · 2014

  92. 0.69

    An Inverse U-Shaped Curve of Resting-State Networks in Individuals at High Risk of Alzheimer's Disease

    Ye Q, Chen H, Su F et al. · The Journal of clinical psychiatry · 2018

  93. 0.69

    Sex Moderates Amyloid and Apolipoprotein epsilon4 Effects on Default Mode Network Connectivity at Rest

    Caldwell JZK, Zhuang X, Leavitt MJ et al. · Frontiers in neurology · 2019

  94. 0.69

    Convergent and divergent effects of apolipoprotein E epsilon4 and epsilon2 alleles on amygdala functional networks in nondemented older adults

    Gong L, Shu H, He C et al. · Neurobiology of aging · 2017

  95. 0.69

    Interaction of age and APOE genotype on cerebral blood flow at rest

    Wierenga CE, Clark LR, Dev SI et al. · Journal of Alzheimer's disease : JAD · 2013

  96. 0.69

    Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults

    Okonkwo OC, Xu G, Dowling NM et al. · Neurology · 2012

  97. 0.68

    APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia

    Vipin A, Kumar D, Soo SA et al. · Alzheimer's research & therapy · 2023

  98. 0.68

    Association of APOE rs405509 (-219 T/G) with multidimensional cognitive function, brain structure, and resting-state networks in Chinese community-dwelling older adults

    Wang Z, Ding J, Hu X et al. · Brain research bulletin · 2026

  99. 0.67

    Association of rs440446 in the APOE intron region with multidimensional cognitive function, lipid/metabolic markers, and spontaneous neural activity in Chinese urban community-dwelling older adults

    Wang Z, Guo H, Li J et al. · Frontiers in neuroscience · 2025

  100. 0.67

    Identification of Alzheimer disease risk by functional magnetic resonance imaging

    Fleisher AS, Houston WS, Eyler LT et al. · Archives of neurology · 2005

  101. 0.67

    Cardiovascular risk of dementia is associated with brain-behaviour changes in cognitively healthy, middle-aged individuals

    Deng F, Dounavi ME, Plini ERG et al. · Neurobiology of aging · 2024

  102. 0.67

    Cerebral hypoperfusion, brain structural integrity, and cognitive impairment in older APOE4 carriers

    Pappas I, Lohman T, Dutt S et al. · GeroScience · 2025

  103. 0.67

    Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease

    Tremblay SA, Nathan Spreng R, Wearn A et al. · Neurobiology of aging · 2025

  104. 0.67

    Association of fish oil supplement use with preservation of brain volume and cognitive function

    Daiello LA, Gongvatana A, Dunsiger S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015

  105. 0.67

    A physically and mentally active lifestyle relates to younger brain and cognitive age

    Behrenbruch N, Schwarck S, Schumann-Werner B et al. · GeroScience · 2026

  106. 0.67

    APOE 𝜀4-related blood-brain barrier breakdown is associated with microstructural abnormalities

    Reas ET, Solders SK, Tsiknia A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  107. 0.66

    APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders

    Yin Z, Wu W, Liu R et al. · PeerJ · 2015

  108. 0.66

    Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele

    Kim SM, Kim MJ, Rhee HY et al. · Neuroradiology · 2013

  109. 0.66

    Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE epsilon4 gene carriers

    Elahi FM, Ashimatey SB, Bennett DJ et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  110. 0.66

    Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936

    Lyall DM, Harris SE, Bastin ME et al. · Neurobiology of aging · 2014

  111. 0.65

    Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study

    Trivedi MA, Schmitz TW, Ries ML et al. · BMC medicine · 2006

  112. 0.65

    The Effect of the APOE-epsilon4 Allele on the Cholinergic Circuitry for Subjects With Different Levels of Cognitive Impairment

    Lai YLL, Chen K, Lee TW et al. · Frontiers in neurology · 2021

  113. 0.65

    Associations of Coffee and Tea Consumption on Neural Network Connectivity: Unveiling the Role of Genetic Factors in Alzheimer's Disease Risk

    Li T, Fili M, Mohammadiarvejeh P et al. · Nutrients · 2024

  114. 0.65

    Traumatic brain injury, Apolipoprotein E-epsilon4, and cognition in older adults: a two-year longitudinal study

    Rapoport M, Wolf U, Herrmann N et al. · The Journal of neuropsychiatry and clinical neurosciences · 2008

  115. 0.65

    Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired Individuals

    Skampardoni I, Nasrallah IM, Abdulkadir A et al. · JAMA psychiatry · 2024

  116. 0.65

    The apolipoprotein E gene affects the three-year trajectories of compensatory neural processes in the left-lateralized hippocampal network

    Ye Q, Su F, Shu H et al. · Brain imaging and behavior · 2017

  117. 0.65

    APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study

    Camarda C, Torelli P, Pipia C et al. · Current Alzheimer research · 2020

  118. 0.65

    White Matter Abnormalities and Cognition in Aging and Alzheimer Disease

    Peter C, Sathe A, Shashikumar N et al. · JAMA neurology · 2025

  119. 0.64

    Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer's disease

    Ben-Ami L, Ravona-Springer R, Tsarfaty G et al. · Frontiers in aging neuroscience · 2023

  120. 0.64

    Free-water imaging of the nucleus basalis of Meynert in apolipoprotein E4 carriers

    Ofori E, Braden BB, Chen K et al. · Frontiers in aging neuroscience · 2025

  121. 0.64

    Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study

    Bangen KJ, Restom K, Liu TT et al. · Journal of Alzheimer's disease : JAD · 2012

  122. 0.64

    Aperiodic EEG signatures: unveiling the interplay between APOE epsilon4 and mild cognitive impairment subtypes

    Eyamu J, Ku B, Kim K et al. · Frontiers in aging neuroscience · 2025

  123. 0.63

    Apolipoprotein epsilon4 is associated with lower brain volume in cognitively normal Chinese but not white older adults

    Yokoyama JS, Lee AKL, Takada LT et al. · PloS one · 2015

  124. 0.63

    Pulse pressure and APOE epsilon4 dose interact to affect cerebral blood flow in older adults without dementia

    Edwards L, Thomas KR, Weigand AJ et al. · Cerebral circulation - cognition and behavior · 2024

  125. 0.63

    Lower neurovascular coupling response despite higher cerebral blood flow at rest in apolipoprotein varepsilon4 positive adults

    Pearson AG, Miller KB, Corkery AT et al. · PloS one · 2024

  126. 0.62

    Cardiometabolic risk factors predict cerebrovascular health in older adults: results from the Brain in Motion study

    Tyndall AV, Argourd L, Sajobi TT et al. · Physiological reports · 2016

  127. 0.62

    Elevated functional magnetic resonance imaging activity in cognitively normal participants predicts future dementia

    Clemens SG, Hobbs DA, McKay NS et al. · Brain communications · 2026

  128. 0.62

    APOE4 carriers display loss of anticipatory cerebral vascular regulation over AD progression

    Palmer JA, Kaufman CS, Whitaker-Hilbig AA et al. · medRxiv : the preprint server for health sciences · 2024

  129. 0.62

    Anxiety correlates with cortical surface area in subjective cognitive decline: APOE epsilon4 carriers versus APOE epsilon4 non-carriers

    Sun Y, Wang X, Wang Y et al. · Alzheimer's research & therapy · 2019

  130. 0.61

    Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults

    Grau-Rivera O, Operto G, Falcon C et al. · Alzheimer's research & therapy · 2020

  131. 0.60

    APOE varepsilon4 exacerbates age-dependent deficits in cortical microstructure

    Mak E, Dounavi ME, Operto G et al. · Brain communications · 2024

  132. 0.60

    Predicting the apolipoprotein E epsilon4 allele carrier status based on gray matter volumes and cognitive function

    Kim HG, Tian Y, Jung SM et al. · Brain and behavior · 2024

  133. 0.59

    Disrupted topology of the resting state structural connectome in middle-aged APOE epsilon4 carriers

    Korthauer LE, Zhan L, Ajilore O et al. · NeuroImage · 2018

  134. 0.59

    Apolipoprotein epsilon4 modifies obesity-related atrophy in the hippocampal formation of cognitively healthy adults

    Coad BM, Ghomroudi PA, Sims R et al. · Neurobiology of aging · 2022

  135. 0.59

    Dissecting the gene dose-effects of the APOE epsilon4 and epsilon2 alleles on hippocampal volumes in aging and Alzheimer's disease

    Hostage CA, Roy Choudhury K, Doraiswamy PM et al. · PloS one · 2013

  136. 0.58

    The APOE varepsilon4 allele affects complexity and functional connectivity of resting brain activity in healthy adults

    Yang AC, Huang CC, Liu ME et al. · Human brain mapping · 2014

  137. 0.58

    Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

    Harrison TM, McLaren DG, Moody TD et al. · Journal of visualized experiments : JoVE · 2017

  138. 0.57

    Obesity, cardiometabolic health status, and brain health in community-dwelling older adults

    Alphin KH, Suerken CK, Rudolph MD et al. · Journal of Alzheimer's disease : JAD · 2026

  139. 0.56

    Apolipoprotein E (APOE) epsilon4 moderates the relationship between c-reactive protein, cognitive functioning, and white matter integrity

    Wooten T, Brown E, Sullivan DR et al. · Brain, behavior, and immunity · 2021

  140. 0.56

    The Role of MRI Biomarkers and Their Interactions with Cognitive Status and APOE epsilon4 in Nondemented Elderly Subjects

    Liang X, Yin Z, Liu R et al. · Neuro-degenerative diseases · 2018

  141. 0.56

    Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI)

    Ngwa JS, Fungwe TV, Ntekim O et al. · Dementia and geriatric cognitive disorders · 2018

  142. 0.56

    Evaluating Cerebral Perfusion in Alzheimer Patients and First-Degree Relatives: Lessons from Artemisa Province, Cuba

    Pena-Quian Y, Sosa-Perez S, Batista-Cuellar JF et al. · MEDICC review · 2021

  143. 0.55

    Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort

    Teng E, Chow N, Hwang KS et al. · Dementia and geriatric cognitive disorders · 2015

  144. 0.55

    Machine learning-based estimation of cognitive performance using regional brain MRI markers: the Northern Manhattan Study

    Caunca MR, Wang L, Cheung YK et al. · Brain imaging and behavior · 2021

  145. 0.54

    Interactive effect of age and APOE-epsilon4 allele load on white matter myelin content in cognitively normal middle-aged subjects

    Operto G, Molinuevo JL, Cacciaglia R et al. · NeuroImage. Clinical · 2019

  146. 0.54

    Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease

    Smith JC, Nielson KA, Woodard JL et al. · Frontiers in aging neuroscience · 2014

  147. 0.53

    Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults

    Walker KA, Gross AL, Moghekar AR et al. · Brain, behavior, and immunity · 2020

  148. 0.53

    Impact of apolipoprotein E epsilon4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging

    Chang L, Andres M, Sadino J et al. · NeuroImage · 2011

  149. 0.53

    Predicting longitudinal basal forebrain volume in the Alzheimer's disease spectrum: the role of sex and ApoE epsilon 4 genotype

    Grazia A, Levin F, Jessen F et al. · Frontiers in neuroscience · 2026

  150. 0.53

    Disrupted Brain Structural Connectivity: Pathological Interactions Between Genetic APOE epsilon4 Status and Developed MCI Condition

    Ma C, Wang J, Zhang J et al. · Molecular neurobiology · 2017

  151. 0.52

    Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults

    Jefferson AL, Cambronero FE, Liu D et al. · Circulation · 2018

  152. 0.52

    Multimodal Retinal Imaging Correlates With Brain Atrophy and Plasma Biomarkers in Alzheimer's Disease

    Luan X, Shen J, Wang Y et al. · Translational vision science & technology · 2026

  153. 0.51

    Family history of Alzheimer's disease and hippocampal structure in healthy people

    Donix M, Burggren AC, Suthana NA et al. · The American journal of psychiatry · 2010

  154. 0.51

    Effects of functional variants of vitamin C transporter genes on apolipoprotein E E4-associated risk of cognitive decline: The Nakajima study

    Hayashi K, Noguchi-Shinohara M, Sato T et al. · PloS one · 2021

  155. 0.51

    MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

    Ten Kate M, Redolfi A, Peira E et al. · Alzheimer's research & therapy · 2018

  156. 0.51

    Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults

    Johnson SC, Ries ML, Hess TM et al. · Archives of general psychiatry · 2007

  157. 0.50

    Reproductive lifespan and hormonal therapy in relation to later-life neurovascular health: A population-based study of women in the Gothenburg H70-1944 Birth Cohort

    Lorenzon G, Garcia-Lluch G, Coughlan G et al. · medRxiv : the preprint server for health sciences · 2026

  158. 0.50

    Fitness, independent of physical activity is associated with cerebral blood flow in adults at risk for Alzheimer's disease

    Dougherty RJ, Boots EA, Lindheimer JB et al. · Brain imaging and behavior · 2020

  159. 0.50

    Vascular and microstructural markers of cognitive pathology

    Coffin C, Suerken CK, Bateman JR et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022

03pet · amyloid97편

  1. 0.95

    Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals

    Lim YY, Williamson R, Laws SM et al. · Journal of Alzheimer's disease : JAD · 2017

  2. 0.94

    Learning deficit in cognitively normal APOE epsilon4 carriers with LOW beta-amyloid

    Lim YY, Baker JE, Mills A et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  3. 0.93

    Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

    Lim YY, Ellis KA, Pietrzak RH et al. · Neurology · 2012

  4. 0.93

    Association of beta-Amyloid and Apolipoprotein E epsilon4 With Memory Decline in Preclinical Alzheimer Disease

    Lim YY, Kalinowski P, Pietrzak RH et al. · JAMA neurology · 2018

  5. 0.93

    Impact of APOE epsilon4 Carrier Status on Associations Between Subthreshold, Positive Amyloid-beta Deposition, Brain Function, and Cognitive Performance in Cognitively Normal Older Adults: A Prospective Study

    Kang DW, Wang SM, Um YH et al. · Frontiers in aging neuroscience · 2022

  6. 0.93

    APOE modifies the association between Abeta load and cognition in cognitively normal older adults

    Kantarci K, Lowe V, Przybelski SA et al. · Neurology · 2012

  7. 0.92

    APOE and amyloid-tau pathology in cognitively unimpaired older adults

    Albarran Morillo C, Zheng L, Ghanbarian E et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  8. 0.90

    Synergistic effects of APOE epsilon4 and Alzheimer's pathology on the neural correlates of episodic remembering in cognitively unimpaired older adults

    Trelle AN, Sheng J, Wilson EN et al. · bioRxiv : the preprint server for biology · 2025

  9. 0.90

    Associations Between Sub-Threshold Amyloid-beta Deposition, Cortical Volume, and Cognitive Function Modulated by APOE varepsilon4 Carrier Status in Cognitively Normal Older Adults

    Kang DW, Wang SM, Um YH et al. · Journal of Alzheimer's disease : JAD · 2022

  10. 0.89

    Abeta amyloid, cognition, and APOE genotype in healthy older adults

    Lim YY, Ellis KA, Ames D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013

  11. 0.89

    Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE epsilon4

    Jung JH, Kong N, Lee S · The journal of prevention of Alzheimer's disease · 2025

  12. 0.89

    Age, Sex, and APOE epsilon4 Effects on Memory, Brain Structure, and beta-Amyloid Across the Adult Life Span

    Jack CRJ, Wiste HJ, Weigand SD et al. · JAMA neurology · 2015

  13. 0.88

    Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE4 Carriers

    Fischer L, Molloy EN, Pichet Binette A et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025

  14. 0.88

    The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort

    Li C, Loewenstein DA, Duara R et al. · Journal of Alzheimer's disease : JAD · 2017

  15. 0.88

    Lifestyle, APOE epsilon4, amyloid burden, and race/ethnicity differences in cognition, mood, and anxiety among cognitively unimpaired older adults

    Li S, Yu Y, Cunanan V et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  16. 0.87

    APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia

    Weigand AJ, Thomas KR, Bangen KJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021

  17. 0.87

    Cerebrovascular response to exercise interacts with individual genotype and amyloid-beta deposition to influence response inhibition with aging

    Palmer JA, Kaufman CS, Vidoni ED et al. · Neurobiology of aging · 2022

  18. 0.86

    Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden

    Lin Z, Sur S, Soldan A et al. · Radiology · 2019

  19. 0.86

    beta-Amyloid burden in healthy aging: regional distribution and cognitive consequences

    Rodrigue KM, Kennedy KM, Devous MDS et al. · Neurology · 2012

  20. 0.86

    Sex-related differences in the relationship between beta-amyloid and cognitive trajectories in older adults

    Lindbergh CA, Casaletto KB, Staffaroni AM et al. · Neuropsychology · 2020

  21. 0.85

    APOE-epsilon4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals

    Brugulat-Serrat A, Sanchez-Benavides G, Cacciaglia R et al. · EJNMMI research · 2023

  22. 0.84

    Differential Effects of the Interaction Between the Education and APOE epsilon4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients

    Kang DW, Wang SM, Na HR et al. · Current Alzheimer research · 2020

  23. 0.84

    Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly

    Kim YJ, Yun J, Seo SW et al. · European journal of neurology · 2024

  24. 0.83

    APOE epsilon4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly

    Snellman A, Ekblad LL, Tuisku J et al. · Alzheimer's research & therapy · 2023

  25. 0.83

    Cortical beta-amyloid burden, gray matter, and memory in adults at varying APOE epsilon4 risk for Alzheimer's disease

    Mecca AP, Barcelos NM, Wang S et al. · Neurobiology of aging · 2018

  26. 0.83

    Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population

    Gu Y, Razlighi QR, Zahodne LB et al. · PloS one · 2015

  27. 0.83

    Sex and APOE varepsilon4 modify the effect of cardiovascular risk on tau in cognitively normal older adults

    Tsiknia AA, Reas E, Bangen KJ et al. · Brain communications · 2022

  28. 0.83

    Cognition at age 70: Life course predictors and associations with brain pathologies

    Lu K, Nicholas JM, Collins JD et al. · Neurology · 2019

  29. 0.82

    SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE epsilon4/epsilon4 homozygotes

    Snellman A, Tuisku J, Koivumaki M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  30. 0.82

    Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals

    Sperling RA, Donohue MC, Raman R et al. · JAMA neurology · 2020

  31. 0.80

    Disrupted excitation-inhibition balance in cognitively normal individuals at risk of Alzheimer's disease

    Fortel I, Zhan L, Ajilore O et al. · bioRxiv : the preprint server for biology · 2023

  32. 0.78

    Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline

    Stonnington CM, Velgos SN, Chen Y et al. · Journal of Alzheimer's disease : JAD · 2020

  33. 0.78

    Polymorphism of brain derived neurotrophic factor influences beta amyloid load in cognitively intact apolipoprotein E epsilon4 carriers

    Adamczuk K, De Weer AS, Nelissen N et al. · NeuroImage. Clinical · 2013

  34. 0.78

    Association of circulating proteasome activity with Alzheimer's pathology and cognitive functions in APOE epsilon4 carriers

    Koo BG, Seo HE, Yun Y et al. · Alzheimer's research & therapy · 2026

  35. 0.77

    Klotho allele status is not associated with Abeta and APOE epsilon4-related cognitive decline in preclinical Alzheimer's disease

    Porter T, Burnham SC, Milicic L et al. · Neurobiology of aging · 2019

  36. 0.77

    Sex and APOE genotype differences in amyloid deposition and cognitive performance along the Alzheimer's Continuum

    Pan F, Wang Y, Wang Y et al. · Neurobiology of aging · 2023

  37. 0.77

    Both sides of the bell curve: Base rates of high and low scores in cognitively unimpaired and impaired older adults and their relationship to biomarkers of Alzheimer's disease

    Duff K, Presley C, King JB et al. · Journal of the International Neuropsychological Society : JINS · 2025

  38. 0.77

    Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment

    Blautzik J, Kotz S, Brendel M et al. · Journal of Alzheimer's disease : JAD · 2018

  39. 0.74

    Modulation of associations between education years and cortical volume in Alzheimer's disease vulnerable brain regions by Abeta deposition and APOE epsilon4 carrier status in cognitively normal older adults

    Kim HB, Kim SH, Um YH et al. · Frontiers in aging neuroscience · 2023

  40. 0.74

    Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study

    Burnham SC, Bourgeat P, Dore V et al. · The Lancet. Neurology · 2016

  41. 0.74

    Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study

    Kemppainen N, Johansson J, Teuho J et al. · Neurology · 2018

  42. 0.73

    Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers

    Li A, Du J, Cai Y et al. · Journal of Alzheimer's disease : JAD · 2023

  43. 0.73

    APOE4 moderates the association of sleep disturbance with cerebral amyloid burden but not with clinical conversion in cognitively normal older adults

    Lee MJ, Kim JH, Choi HJ et al. · Journal of Alzheimer's disease : JAD · 2026

  44. 0.72

    Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE epsilon4-dependent manner

    Rubinski A, Dewenter A, Zheng L et al. · European journal of nuclear medicine and molecular imaging · 2024

  45. 0.72

    Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease

    Pardo JV, Lee JT · eNeuro · 2018

  46. 0.71

    Association of neighborhood deprivation with Alzheimer's Disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE epsilon4 status

    Aguilar-Dominguez P, Colceriu CM, Holland TM et al. · medRxiv : the preprint server for health sciences · 2026

  47. 0.71

    Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding

    Siddarth P, Burggren AC, Merrill DA et al. · PloS one · 2018

  48. 0.71

    Periventricular diffusivity reflects APOE epsilon4-modulated amyloid accumulation and cognitive impairment in the Alzheimer's disease continuum

    Chen CL, Son SJ, Schweitzer N et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  49. 0.70

    APOE4-specific glymphatic effects on clinical progression in the Alzheimer's Disease Neuroimaging Initiative with pathological correlates in the A4 study

    Saadawy M, Majeed M, Saadawy E · Journal of Alzheimer's disease : JAD · 2026

  50. 0.70

    Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer's disease

    Duff K, Suhrie KR, Hammers DB et al. · The Clinical neuropsychologist · 2023

  51. 0.70

    Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study

    Pieperhoff L, Lorenzini L, Mastenbroek S et al. · NeuroImage. Clinical · 2025

  52. 0.68

    18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons

    Knopman DS, Jack CRJ, Wiste HJ et al. · Neurobiology of aging · 2014

  53. 0.68

    Midlife Lifestyle Activities Moderate APOE epsilon4 Effect on in vivo Alzheimer's Disease Pathologies

    Jeon SY, Byun MS, Yi D et al. · Frontiers in aging neuroscience · 2020

  54. 0.68

    Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment

    Seo EH, Kim SH, Park SH et al. · Journal of Korean medical science · 2016

  55. 0.68

    Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies

    Tariot PN, Riviere ME, Salloway S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  56. 0.68

    Longitudinal change in ATN biomarkers in cognitively normal individuals

    Ebenau JL, Visser D, Kroeze LA et al. · Alzheimer's research & therapy · 2022

  57. 0.67

    Effect of APOE epsilon4 genotype on amyloid-beta, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment

    Li W, Li R, Yan S et al. · European journal of neurology · 2023

  58. 0.67

    APOE epsilon4-associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum

    Mares J, Kumar G, Sharma A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  59. 0.67

    Association of Brain Amyloid-beta With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E epsilon4 Genotype

    Nadkarni NK, Perera S, Snitz BE et al. · JAMA neurology · 2017

  60. 0.67

    Tau Pathology in the Medial Temporal Lobe and Neocortex: Implications for Cognitive Unimpaired in Cognitively Unimpaired Older Adults

    Demirsoy I · Balkan medical journal · 2025

  61. 0.66

    Moderating effect of APOE epsilon4 on the association of sleep disturbance and amyloid-beta pathology among cognitively normal older adults

    Feng S, Que J, Wang Q et al. · Frontiers in aging neuroscience · 2025

  62. 0.66

    The relationships between ethnoracial identity, Abeta positivity, APOEepsilon4, and medial temporal lobe tau PET

    Wheeler KV, Tennant VR, Lee NN et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  63. 0.66

    Defining the contributions of tau pathology in the amygdala to increasing depressive symptoms in aging

    Markova TZ, Fonseca CS, Ciampa CJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  64. 0.66

    APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42

    Sheline YI, Morris JC, Snyder AZ et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010

  65. 0.64

    The preclinical amyloid sensitive composite to determine subtle cognitive differences in preclinical Alzheimer's disease

    Hahn A, Kim YJ, Kim HJ et al. · Scientific reports · 2020

  66. 0.64

    Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort

    Ihara R, Iwata A, Suzuki K et al. · Alzheimer's & dementia (New York, N. Y.) · 2018

  67. 0.64

    Fibrillar amyloid correlates of preclinical cognitive decline

    Stonnington CM, Chen K, Lee W et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014

  68. 0.63

    Neighborhood socioeconomic deprivation is associated with worse cognitive performance and in vivo amyloid accumulation

    Mayeli M, Saraiya R, Mecca AP et al. · NPJ dementia · 2026

  69. 0.63

    Longitudinal assessment of amyloid-beta deposition in initially amyloid-negative non-demented individuals with [11C]-PIB PET imaging

    Hatashita S, Wakebe D · Medicine · 2021

  70. 0.62

    APOE4-dependent association between metformin use and Alzheimer's disease-related cortical thickness in older adults with type 2 diabetes

    Kim M, Byun MS, Yi D et al. · Journal of Alzheimer's disease : JAD · 2026

  71. 0.62

    Serum zinc levels and in vivo beta-amyloid deposition in the human brain

    Kim JW, Byun MS, Yi D et al. · Alzheimer's research & therapy · 2021

  72. 0.60

    Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals

    Cedres N, Ferreira D, Nemy M et al. · Neurology · 2022

  73. 0.59

    Spatial Extent of Amyloid-beta Levels and Associations With Tau-PET and Cognition

    Ozlen H, Pichet Binette A, Kobe T et al. · JAMA neurology · 2022

  74. 0.58

    (1)H-MRS metabolites and rate of beta-amyloid accumulation on serial PET in clinically normal adults

    Nedelska Z, Przybelski SA, Lesnick TG et al. · Neurology · 2017

  75. 0.58

    Influence of APOE genotype in primary age-related tauopathy

    Robinson AC, Davidson YS, Roncaroli F et al. · Acta neuropathologica communications · 2020

  76. 0.58

    The links among age, sex, and glutathione: A cross-sectional magnetic resonance spectroscopy study

    Michels L, O'Gorman-Tuura R, Bachmann D et al. · Neurobiology of aging · 2024

  77. 0.57

    Glucose metabolism and gray-matter concentration in apolipoprotein E epsilon4 positive normal subjects

    Samuraki M, Matsunari I, Chen WP et al. · Neurobiology of aging · 2012

  78. 0.57

    Predicting biomarkers in intact older adults and those with amnestic Mild Cognitive Impairment, and mild Alzheimer's Disease using the Repeatable Battery for the Assessment of Neuropsychological Status

    Suhrie KR, Hammers DB, Porter SM et al. · Journal of clinical and experimental neuropsychology · 2021

  79. 0.57

    Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study

    Jack CRJ, Wiste HJ, Weigand SD et al. · The Lancet. Neurology · 2017

  80. 0.57

    Temporal sequence of amyloid and tau PET positivity: APOE -epsilon4 and sex effects, and implications for Alzheimer's disease progression

    Mila-Aloma M, Hausle I, Petersen KK et al. · medRxiv : the preprint server for health sciences · 2025

  81. 0.55

    ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels

    Steward A, Biel D, Dewenter A et al. · JAMA neurology · 2023

  82. 0.55

    Gene-environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden

    Wirth M, Villeneuve S, La Joie R et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014

  83. 0.55

    Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD

    Wang X, Sundermann EE, Buckley RF et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  84. 0.54

    Brain injury biomarkers are not dependent on beta-amyloid in normal elderly

    Knopman DS, Jack CRJ, Wiste HJ et al. · Annals of neurology · 2013

  85. 0.53

    Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention

    Cody KA, Koscik RL, Erickson CM et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022

  86. 0.52

    Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

    Jack CRJ, Wiste HJ, Therneau TM et al. · JAMA · 2019

  87. 0.52

    Indicators of amyloid burden in a population-based study of cognitively normal elderly

    Mielke MM, Wiste HJ, Weigand SD et al. · Neurology · 2012

  88. 0.52

    Biomarker and neuropsychological correlates of the N400 event-related potential in Alzheimer's disease

    Geiger AR, Euler MJ, Guevara JE et al. · International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2025

  89. 0.51

    Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

    Schreiber S, Schreiber F, Lockhart SN et al. · JAMA neurology · 2017

  90. 0.51

    Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses

    Rouch L, Virecoulon Giudici K, Cantet C et al. · The American journal of clinical nutrition · 2022

  91. 0.51

    Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment

    van Bergen JMG, Li X, Hua J et al. · Scientific reports · 2016

  92. 0.51

    Neurophysiological and other features of working memory in older adults at risk for dementia

    Patterson RA, Brooks H, Mirjalili M et al. · Cognitive neurodynamics · 2024

  93. 0.51

    Prevalence of preclinical Alzheimer disease: Comparison of current classification systems

    Kern S, Zetterberg H, Kern J et al. · Neurology · 2018

  94. 0.50

    Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease

    Besson FL, La Joie R, Doeuvre L et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015

  95. 0.50

    Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume

    Caldwell JZK, Berg JL, Cummings JL et al. · Alzheimer's research & therapy · 2017

  96. 0.50

    Association of beta-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy

    Rabin JS, Pruzin J, Scott M et al. · Neurology · 2022

  97. 0.50

    Associations of Physical Activity and beta-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults

    Rabin JS, Klein H, Kirn DR et al. · JAMA neurology · 2019

04mini-mental state · examination97편

  1. 0.93

    Social disorder, APOE-E4 genotype, and change in cognitive function among older adults living in Chicago

    Boardman JD, Barnes LL, Wilson RS et al. · Social science & medicine (1982) · 2012

  2. 0.93

    Effects of APOE e4-allele and mental work demands on cognitive decline in old age: Results from the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe)

    Rodriguez FS, Roehr S, Pabst A et al. · International journal of geriatric psychiatry · 2021

  3. 0.93

    APOE epsilon4 and Accelerated Cognitive Decline Among Cognitively Healthy Middle-Aged and Older Adults

    Chung YCE, Chung RH, Hsu CC et al. · JAMA network open · 2026

  4. 0.92

    APOE epsilon4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambui Cohort Study of Aging

    Quintino-Santos S, Diniz BS, Firmo JOA et al. · International journal of geriatric psychiatry · 2015

  5. 0.92

    Do the effects of APOE-epsilon4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging

    Brown B, Huang MH, Karlamangla A et al. · The journal of nutrition, health & aging · 2011

  6. 0.92

    Walking to protect against cognitive decline: the role of APOE genotype and sex

    Burma JS, Rosano C, Best JR et al. · Biology of sex differences · 2026

  7. 0.91

    Interaction between APOE epsilon4 and dietary protein intake on cognitive decline: A longitudinal cohort study

    Zhang Y, Jin X, Lutz MW et al. · Clinical nutrition (Edinburgh, Scotland) · 2021

  8. 0.91

    Influence of APOE4 Genotypes on Nutrient-Cognition Relationship in Taiwanese Older Adults: Longitudinal Findings from the HALST

    Lai RH, Yang SJ, Hsu PY et al. · Nutrients · 2025

  9. 0.91

    Impact of the Apolipoprotein E epsilon4 Allele on the Relationship Between Healthy Lifestyle and Cognitive Decline: A Population-Based Study

    Dhana K, Aggarwal NT, Rajan KB et al. · American journal of epidemiology · 2021

  10. 0.90

    Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction

    Feng L, Li J, Yap KB et al. · The American journal of clinical nutrition · 2009

  11. 0.90

    High-Density Lipoprotein Cholesterol and Cognitive Function in Older Korean Adults Without Dementia: Apolipoprotein E4 as a Moderating Factor

    Choe YM, Choi HJ, Keum M et al. · Nutrients · 2025

  12. 0.90

    Leisure Activities, APOE epsilon4, and Cognitive Decline: A Longitudinal Cohort Study

    Zhang Y, Fu S, Ding D et al. · Frontiers in aging neuroscience · 2021

  13. 0.88

    Apolipoprotein E4 allele, antibodies against periodontal microorganisms, and cognition in older adults

    Merchant AT, Zhao L, Bawa EM et al. · Journal of Alzheimer's disease reports · 2025

  14. 0.88

    APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies

    Niti M, Yap KB, Kua EH et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2009

  15. 0.88

    Associations of cognitive reserve with IGF-1 and global cognition differ by early-life conditions and APOE genotype

    da Silva SP, Lampraki C, Cullati S et al. · Experimental gerontology · 2026

  16. 0.87

    Effects of vascular risk factors and APOE epsilon4 on white matter integrity and cognitive decline

    Wang R, Fratiglioni L, Laukka EJ et al. · Neurology · 2015

  17. 0.87

    Education as a Modifier of Genetic Influence on Cognitive Ability in Older Adults

    Hsu YC, Lin MC, Su MH et al. · Behavior genetics · 2025

  18. 0.87

    APOE genotype and cognitive decline: educational context as a moderator of genetic risk

    Walsemann KM, Jackson HM, Boardman JD et al. · The journals of gerontology. Series B, Psychological sciences and social sciences · 2025

  19. 0.86

    Associations of Vascular Risk Factors, APOE and TOMM40 Polymorphisms With Cognitive Function in Dementia-Free Chinese Older Adults: A Community-Based Study

    Gui W, Qiu C, Shao Q et al. · Frontiers in psychiatry · 2021

  20. 0.86

    Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults

    Thompson LI, Cummings M, Emrani S et al. · The journal of prevention of Alzheimer's disease · 2024

  21. 0.86

    Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population

    Qiu C, Winblad B, Fratiglioni L · Neurological research · 2006

  22. 0.86

    APOE epsilon4 Modifies Effect of Residential Greenness on Cognitive Function among Older Adults: A Longitudinal Analysis in China

    Zhu A, Yan L, Shu C et al. · Scientific reports · 2020

  23. 0.85

    Prospective associations of interleukin-6 and APOE allele with cognitive decline in biracial community-dwelling older adults: The Chicago Health and Aging Project (CHAP)

    Ng TKS, Beck T, Desai P et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  24. 0.85

    Modification of the relationship of the apolipoprotein E epsilon4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep

    Lim ASP, Yu L, Kowgier M et al. · JAMA neurology · 2013

  25. 0.85

    Association of lifetime intellectual enrichment with cognitive decline in the older population

    Vemuri P, Lesnick TG, Przybelski SA et al. · JAMA neurology · 2014

  26. 0.85

    The relationship between midlife and late life alcohol consumption, APOE e4 and the decline in learning and memory among older adults

    Downer B, Zanjani F, Fardo DW · Alcohol and alcoholism (Oxford, Oxfordshire) · 2014

  27. 0.85

    Vitamin D deficiency may accelerate cognitive decline in female apolipoprotein E epsilon4 non-carriers RECODE

    Kim J, Ji E, Bae JB et al. · Clinical nutrition (Edinburgh, Scotland) · 2025

  28. 0.85

    Does NSAID use modify cognitive trajectories in the elderly? The Cache County study

    Hayden KM, Zandi PP, Khachaturian AS et al. · Neurology · 2007

  29. 0.84

    Overlap Between Apolipoprotein Eepsilon4 Allele and Slowing Gait Results in Cognitive Impairment

    Sakurai R, Watanabe Y, Osuka Y et al. · Frontiers in aging neuroscience · 2019

  30. 0.84

    Prosocial helping behaviors attenuate accelerated cognitive decline driven by APOE epsilon4

    Han SH, Faul JD · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  31. 0.84

    Approaches to Timescale Choice in Cognitive Aging Research and Potential Implications for Estimated Exposure Effects: Coordinated Analyses in 10 Cohorts of Older Adults

    Hayes-Larson E, Andrews RM, Kezios KL et al. · Epidemiology (Cambridge, Mass.) · 2025

  32. 0.83

    Meat Consumption and Cognitive Health by APOE Genotype

    Norgren J, Carballo-Casla A, Grande G et al. · JAMA network open · 2026

  33. 0.83

    Cognitive resilience to apolipoprotein E epsilon4: contributing factors in black and white older adults

    Kaup AR, Nettiksimmons J, Harris TB et al. · JAMA neurology · 2015

  34. 0.83

    Nutritional Status and Cognition in Older Adults: Modification by Apolipoprotein E epsilon4

    Choe YM, Kim JH, Choi HJ et al. · Nutrients · 2026

  35. 0.83

    Age-Dependent and APOE-Modified Associations Between Vascular Risk Factor Patterns and Cognitive Function: A Latent Class Analysis of 44,879 NACC Participants

    Kong Y, Li X, Guan R et al. · Alzheimer disease and associated disorders · 2026

  36. 0.83

    The effects of metabolic syndrome and apolipoprotein E4 on cognitive event-related potentials

    Lai CL, Lin RT, Liou LM et al. · Biological psychology · 2010

  37. 0.82

    Longitudinal associations between lipid panel and cognitive decline modified by APOE 4 carrier status in biracial community-dwelling older adults: Findings from the Chicago health and aging project

    Ng TKS, Beck T, Liu X et al. · Archives of gerontology and geriatrics · 2025

  38. 0.82

    A combination of midlife diabetes mellitus and the apolipoprotein E epsilon4 allele increase risk for cognitive decline

    Lee BC, Choe YM, Suh GH et al. · Frontiers in aging neuroscience · 2022

  39. 0.82

    Interaction between arteriosclerosis and the APOE4 gene in cognitive decline in older adults: a cross-sectional study in rural minority areas in western China

    Qu F, Yang X, Yang J et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2022

  40. 0.81

    Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study

    Jia J, Zhao T, Liu Z et al. · BMJ (Clinical research ed.) · 2023

  41. 0.81

    Associations between neighborhood built environment and cognition vary by apolipoprotein E genotype: Multi-Ethnic Study of Atherosclerosis

    Besser L, Galvin JE, Rodriguez D et al. · Health & place · 2019

  42. 0.80

    Depressive symptoms and cognitive decline in community-dwelling older adults

    Kohler S, van Boxtel MPJ, van Os J et al. · Journal of the American Geriatrics Society · 2010

  43. 0.80

    Effects of metabolic syndrome, apolipoprotein E, and CYP46 on cognition among Taiwanese Chinese

    Lai CL, Liou LM, Liu CK et al. · The Kaohsiung journal of medical sciences · 2014

  44. 0.79

    Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults

    Rajan KB, Mcaninch EA, Wilson RS et al. · Neurology · 2024

  45. 0.79

    Youthful Processing Speed in Older Adults: Genetic, Biological, and Behavioral Predictors of Cognitive Processing Speed Trajectories in Aging

    Bott NT, Bettcher BM, Yokoyama JS et al. · Frontiers in aging neuroscience · 2017

  46. 0.78

    Cognitive decline is related to high blood glucose levels in older Chinese adults with the ApoE epsilon3/epsilon3 genotype

    Qiu Q, Lin X, Sun L et al. · Translational neurodegeneration · 2019

  47. 0.77

    Albumin, apolipoprotein E-epsilon4 and cognitive decline in community-dwelling Chinese older adults

    Ng TP, Niti M, Feng L et al. · Journal of the American Geriatrics Society · 2009

  48. 0.76

    The impact of nutrient-based dietary patterns on cognitive decline in older adults

    Prinelli F, Fratiglioni L, Musicco M et al. · Clinical nutrition (Edinburgh, Scotland) · 2019

  49. 0.76

    Cortisol and 10-Year Cognitive Decline in Older People From the General Population

    Amendola S, Ouanes S, Zullo L et al. · European journal of neurology · 2025

  50. 0.75

    Predictors and Implications of Accelerated Cognitive Aging

    Levine ME, Harrati A, Crimmins EM · Biodemography and social biology · 2018

  51. 0.75

    Healthy lifestyle factors outweigh influence of APOE genetic risk on extending cognitively healthy life expectancy among Chinese older adults: evidence from a nationwide cohort study

    Ren L, Hu F, Walsh S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  52. 0.74

    APOE epsilon4 and Decline in Health and Financial Literacy in Advanced Age

    Stewart CC, Yu L, Kapasi A et al. · Journal of the American Geriatrics Society · 2026

  53. 0.73

    Late-life physical activity, midlife-to-late-life activity patterns, APOE epsilon4 genotype, and cognitive impairment among Chinese older adults: a population-based observational study

    Zhao X, Wu X, Ma T et al. · The international journal of behavioral nutrition and physical activity · 2025

  54. 0.72

    Predictors of cognitive and physical decline: Results from the Health Aging and Body Composition Study

    Handing EP, Hayden KM, Leng XI et al. · Frontiers in aging neuroscience · 2023

  55. 0.72

    Long-term exposure to ambient air pollution, APOE-epsilon4 status, and cognitive decline in a cohort of older adults in northern Manhattan

    Kulick ER, Elkind MSV, Boehme AK et al. · Environment international · 2020

  56. 0.72

    Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease

    Pettigrew C, Soldan A, Li S et al. · Cognitive neuroscience · 2013

  57. 0.70

    History of incarceration and age-related neurodegeneration: Testing models of genetic and environmental risks in a longitudinal panel study of older adults

    Tanksley PT, Logan MW, Barnes JC · PloS one · 2023

  58. 0.69

    Lifestyle, genetic risk, plasma pTau217, and incident cognitive impairment in WRAP

    Studer RL, Cody KA, Oomens JE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  59. 0.69

    Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition

    Negash S, Wilson RS, Leurgans SE et al. · Current Alzheimer research · 2013

  60. 0.68

    Dietary Patterns High in Red Meat, Potato, Gravy, and Butter Are Associated with Poor Cognitive Functioning but Not with Rate of Cognitive Decline in Very Old Adults

    Granic A, Davies K, Adamson A et al. · The Journal of nutrition · 2016

  61. 0.68

    Arterial compliance, assessed by PTC1 and PTC2 from radial artery pressure waveforms, and cognitive performance: The Multi-Ethnic Study of Atherosclerosis

    Brumback LC, Jacobs DRJ, Duprez DA et al. · Journal of human hypertension · 2026

  62. 0.68

    Associations of the LIBRA index with cognitive resilience to genetic susceptibility to dementia

    Wagner M, Neuffer J, Le Grand Q et al. · American journal of epidemiology · 2025

  63. 0.67

    Elevated gonadotropins and risk of dementia in Chinese adults aged over 80: a cross-sectional study

    Zhu Y, Tu Y, Ren C et al. · Frontiers in aging neuroscience · 2025

  64. 0.66

    APOE genotypes modify the obesity paradox in dementia

    Shinohara M, Gheni G, Hitomi J et al. · Journal of neurology, neurosurgery, and psychiatry · 2023

  65. 0.66

    Networks of inflammation, depression, and cognition in aging males and females

    Chalmers RA, Cervin M, Choo C et al. · Aging clinical and experimental research · 2022

  66. 0.65

    Interplay of accelerated biological aging, lifestyle factors, and genetic susceptibility in cognitive function: a community study

    Ma T, Chen X, Zhao Q et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026

  67. 0.65

    APOE epsilon4 allele modifies the associations of toxic metals and their mixture with cognitive impairment among older adults

    Liu Q, Li J, Cheng X et al. · Environmental research · 2024

  68. 0.64

    Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study

    Kolli A, Zhou Y, Chung G et al. · BMC geriatrics · 2022

  69. 0.64

    Potential role of APOE varepsilon4 allele as a modifier for the association of BDNF Val66Met polymorphisms and cognitive impairment in community-dwelling older adults

    Ji S, Kang J, Han C et al. · Frontiers in aging neuroscience · 2024

  70. 0.64

    ApoE and quality of life in nonagenarians

    Parsaik AK, Lapid MI, Rummans TA et al. · Journal of the American Medical Directors Association · 2012

  71. 0.63

    Vitamin B and One-Carbon Metabolite Profiles Show Divergent Associations with Cardiometabolic Risk Markers but not Cognitive Function in Older New Zealand Adults: A Secondary Analysis of the REACH Study

    Gillies NA, Milan AM, Cameron-Smith D et al. · The Journal of nutrition · 2023

  72. 0.63

    Association between vitamin A, vitamin E and apolipoprotein E status with mild cognitive impairment among elderly people in low-cost residential areas

    Shahar S, Lee LK, Rajab N et al. · Nutritional neuroscience · 2013

  73. 0.63

    Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status

    Walker JM, Richardson TE · Journal of neuropathology and experimental neurology · 2023

  74. 0.62

    A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated by the environment

    Yen YC, Rebok GW, Yang MJ et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2008

  75. 0.62

    Association of genetic risk of Alzheimer's disease and cognitive function in two European populations

    Wang B, Chibnik LB, Choi SH et al. · Scientific reports · 2025

  76. 0.61

    Self-reported Lifestyle Activities in Relation to Longitudinal Cognitive Trajectories

    Pettigrew C, Shao Y, Zhu Y et al. · Alzheimer disease and associated disorders · 2019

  77. 0.61

    Chronic Status of Serum Albumin and Cognitive Function: A Retrospective Cohort Study

    Min JY, Ha SW, Yang SH et al. · Journal of clinical medicine · 2022

  78. 0.61

    Polygenic score modifies risk for Alzheimer's disease in APOE epsilon4 homozygotes at phenotypic extremes

    Huq AJ, Fulton-Howard B, Riaz M et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  79. 0.61

    Associations between cognitive function and endogenous levels of estradiol and testosterone in adults with type 2 diabetes

    Espeland MA, Howard M, Bennett W et al. · Journal of diabetes and its complications · 2022

  80. 0.61

    Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia

    Koch M, DeKosky ST, Goodman M et al. · JAMA network open · 2020

  81. 0.60

    Homozygosity for the APOE E4 allele is solely associated with lower cognitive performance in Brazilian community-dwelling older adults: the Bambui Study

    Quintino-Santos SR, Lima-Costa MF, Uchoa E et al. · Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2012

  82. 0.60

    Associations of plasma persistent organic pollutants with brain atrophy, cognitive decline and risk of dementia in older adults

    Lefevre-Arbogast S, Scala P, Zorilla A et al. · Environment international · 2025

  83. 0.60

    Cognitive decline in older adults with epilepsy: The Cardiovascular Health Study

    Choi H, Thacker EL, Longstreth WTJ et al. · Epilepsia · 2021

  84. 0.59

    Sex and genetic differences in postoperative cognitive dysfunction: a longitudinal cohort analysis

    Schenning KJ, Murchison CF, Mattek NC et al. · Biology of sex differences · 2019

  85. 0.58

    Self-reported sleep characteristics associated with dementia among rural-dwelling Chinese older adults: a population-based study

    Liu R, Tang S, Wang Y et al. · BMC neurology · 2022

  86. 0.57

    Homozygosity in the ApoE 4 polymorphism is associated with dysphagic symptoms in older adults

    Mentz H, Horan M, Payton A et al. · Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2015

  87. 0.57

    APOE epsilon4 allele carriers: Biological, psychological, and social variables associated with cognitive impairment

    Sachs-Ericsson NJ, Sawyer KA, Corsentino EA et al. · Aging & mental health · 2010

  88. 0.57

    Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease

    Creese B, Arathimos R, Aarsland D et al. · Alzheimer's & dementia (New York, N. Y.) · 2023

  89. 0.56

    Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study

    Liew TM · The Australian and New Zealand journal of psychiatry · 2022

  90. 0.55

    Sex differences in associations between APOE epsilon2 and longitudinal cognitive decline

    Wood ME, Xiong LY, Wong YY et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  91. 0.53

    Quantitative estimate of cognitive resilience and its medical and genetic associations

    Phongpreecha T, Godrich D, Berson E et al. · Alzheimer's research & therapy · 2023

  92. 0.52

    Apolipoprotein E epsilon4 Modifies the Effect of Possible Anticholinergic Drugs on Incident Dementia: The Shanghai Aging Study

    Chi D, Wu W, Zhao Q et al. · Journal of the American Medical Directors Association · 2023

  93. 0.52

    Educational attainment is associated with reduced functional decline in Puerto Ricans with elevated pTau181

    Dorfsman DA, Cai D, Hamilton-Nelson KL et al. · Journal of Alzheimer's disease : JAD · 2026

  94. 0.51

    Walking time and genetic predisposition for Alzheimer's disease: Results from the HELIAD study

    Sampatakakis SN, Mourtzi N, Charisis S et al. · The Clinical neuropsychologist · 2025

  95. 0.50

    Development of 5-year risk prediction models for incident dementia and mortality in a community-dwelling older Japanese population: The Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)

    Meng X, Honda T, Ohara T et al. · GeroScience · 2026

  96. 0.50

    Late-life, visit-to-visit blood pressure variability and its association with sex-specific long-term cognitive outcomes

    Ernst ME, Sheets KM, Webb KL et al. · Journal of human hypertension · 2025

  97. 0.50

    Cognitive Activities, Lifestyle Factors, and Risk of Cognitive Impairment, with an Analysis of the Apolipoprotein Epsilon 4 Genotype

    Sun Y, Wang Z, Sun S et al. · Gerontology · 2023

05cerebrospinal fluid · csf65편

  1. 0.91

    CSF Abeta(42) and tau biomarkers in cognitively unimpaired Abeta- middle-aged and older APOE epsilon4 carriers

    Lim YY, Yassi N, Bransby L et al. · Neurobiology of aging · 2023

  2. 0.89

    APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline

    Montagne A, Nation DA, Sagare AP et al. · Nature · 2020

  3. 0.88

    Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEvarepsilon4 Carriers

    Hays CC, Zlatar ZZ, Meloy MJ et al. · Journal of Alzheimer's disease : JAD · 2020

  4. 0.87

    Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia

    Bangen KJ, Smirnov DS, Delano-Wood L et al. · Alzheimer's research & therapy · 2021

  5. 0.87

    Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span

    Li G, Millard SP, Peskind ER et al. · JAMA neurology · 2014

  6. 0.86

    Cerebrospinal fluid glial cell line-derived neurotrophic factor levels interact with APOE epsilon4 genotype to influence cognitive decline in older adults without dementia

    Wang S, Zou S · Journal of Alzheimer's disease : JAD · 2026

  7. 0.84

    Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups

    Dubbelman MA, Hendriksen HMA, Harrison JE et al. · Neurology · 2024

  8. 0.84

    The CSF p-tau/beta-amyloid 42 ratio correlates with brain structure and fibrillary beta-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease

    Cacciaglia R, Shekari M, Salvado G et al. · Brain communications · 2025

  9. 0.83

    Higher rates of decline for women and apolipoprotein E epsilon4 carriers

    Holland D, Desikan RS, Dale AM et al. · AJNR. American journal of neuroradiology · 2013

  10. 0.82

    Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer's disease biomarkers

    Boscheck H, Luft M, Mauer R et al. · Alzheimer's research & therapy · 2026

  11. 0.81

    Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults

    Stomrud E, Hansson O, Zetterberg H et al. · Archives of neurology · 2010

  12. 0.80

    Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e

    Susanto TAK, Pua EPK, Zhou J · Journal of Alzheimer's disease : JAD · 2015

  13. 0.79

    Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's Disease

    Pillai JA, Zhu A, Ma C et al. · Annals of clinical and translational neurology · 2026

  14. 0.78

    Alzheimer's disease cerebrospinal fluid biomarker levels and APOE genetic status are associated with hippocampal-cerebellar functional connectivity

    Paitel ER, Pettigrew C, Moghekar A et al. · Neurobiology of aging · 2025

  15. 0.77

    Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease

    Zhao M, Yang J, Cheng H et al. · Journal of Alzheimer's disease : JAD · 2025

  16. 0.77

    Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk

    Lipnicki DM, Valenti M, Valeriano-Lorenzo E et al. · medRxiv : the preprint server for health sciences · 2025

  17. 0.77

    Odor identification as a biomarker of preclinical AD in older adults at risk

    Lafaille-Magnan ME, Poirier J, Etienne P et al. · Neurology · 2017

  18. 0.74

    Associations of Stages of Objective Memory Impairment with Cerebrospinal Fluid and Neuroimaging Biomarkers of Alzheimer's Disease

    Petersen KK, Ezzati A, Lipton RB et al. · The journal of prevention of Alzheimer's disease · 2023

  19. 0.72

    Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

    Bos I, Vos S, Verhey F et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019

  20. 0.71

    Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals

    Song F, Poljak A, Crawford J et al. · PloS one · 2012

  21. 0.70

    The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)

    Risacher SL, Kim S, Shen L et al. · Frontiers in aging neuroscience · 2013

  22. 0.69

    Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non-demented adults

    Ennis GE, Koscik RL, Ma Y et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  23. 0.68

    Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change

    Soldan A, Pettigrew C, Cai Q et al. · JAMA neurology · 2016

  24. 0.67

    CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly

    Shue F, White LJ, Hendrix R et al. · Science advances · 2024

  25. 0.67

    APOE4 genotypes and the trajectory of biomarkers, neuroimaging, and cognitive measures in Alzheimer's Disease: A mixed-effects disease progression model

    Essenburg C, Ramanathan M · Journal of pharmacokinetics and pharmacodynamics · 2025

  26. 0.67

    Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to beta-amyloid positivity

    Mander BA, Dave A, Lui KK et al. · Sleep · 2022

  27. 0.67

    Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease

    Vemuri P, Wiste HJ, Weigand SD et al. · Annals of neurology · 2010

  28. 0.66

    Continuous beta-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity

    Mastenbroek SE, Sala A, Vallez Garcia D et al. · Neurology · 2024

  29. 0.66

    The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data

    Gifford KA, Liu D, Neal JE et al. · Dementia and geriatric cognitive disorders extra · 2018

  30. 0.65

    Interactive effects of arterial stiffness and Alzheimer's disease risk on cognitive decline in older adults without dementia

    Edwards L, Smirnov DS, Thomas KR et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  31. 0.64

    Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease

    Voevodskaya O, Sundgren PC, Strandberg O et al. · Neurology · 2016

  32. 0.64

    Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age

    Sutphen CL, Jasielec MS, Shah AR et al. · JAMA neurology · 2015

  33. 0.63

    Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers

    Roe CM, Ances BM, Head D et al. · Brain : a journal of neurology · 2018

  34. 0.62

    Sex influences the effects of APOE genotype and Alzheimer's diagnosis on neuropathology and memory

    Duarte-Guterman P, Albert AY, Barha CK et al. · Psychoneuroendocrinology · 2021

  35. 0.62

    Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype

    Laczo M, Svacova Z, Lerch O et al. · Journal of neurology · 2025

  36. 0.62

    Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

    Franzmeier N, Suarez-Calvet M, Frontzkowski L et al. · Molecular neurodegeneration · 2020

  37. 0.62

    Trajectory of changes in myelin basic protein levels in cerebrospinal fluid during ageing and its association with biomarkers of Alzheimer's disease

    Xu MY, Yi X, Huang S et al. · Translational psychiatry · 2025

  38. 0.62

    Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer's Disease

    Tsokolas ZE, Asante I, Tsiknia AA et al. · Research square · 2026

  39. 0.61

    Plasma beta(2)-microglobulin and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: the CABLE study

    Huang YM, Ma YH, Gao PY et al. · Alzheimer's research & therapy · 2023

  40. 0.61

    Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease

    Insel PS, Mattsson N, Mackin RS et al. · Annals of clinical and translational neurology · 2015

  41. 0.60

    Longitudinal amyloid PET changes by cerebrospinal fluid amyloid and tau profiles in individuals with normal cognition: Role of APOE epsilon4

    Rizzo M, Oomens JE, Jansen WJ et al. · Journal of Alzheimer's disease : JAD · 2026

  42. 0.59

    Serial MRI and CSF biomarkers in normal aging, MCI, and AD

    Vemuri P, Wiste HJ, Weigand SD et al. · Neurology · 2010

  43. 0.59

    Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1-42

    Schott JM, Bartlett JW, Fox NC et al. · Annals of neurology · 2010

  44. 0.58

    sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer's disease: The CABLE study

    Wang ZB, Sun Y, Ma YH et al. · Translational psychiatry · 2022

  45. 0.56

    Role of family history for Alzheimer biomarker abnormalities in the adult children study

    Xiong C, Roe CM, Buckles V et al. · Archives of neurology · 2011

  46. 0.55

    Cognitive Age Delta as a Marker of Healthy and Pathological Cognitive Aging: The Role of Lifestyle, Cognitive Reserve, and Vascular Risk

    Estanga A, Tellaetxe-Elorriaga I, Ecay-Torres M et al. · Journal of clinical medicine · 2025

  47. 0.55

    Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction

    Duzel E, Ziegler G, Berron D et al. · Brain : a journal of neurology · 2022

  48. 0.55

    Association of CSF GAP-43 and APOE epsilon4 with Cognition in Mild Cognitive Impairment and Alzheimer's Disease

    Zhu Y, Guo X, Zhu F et al. · Cells · 2022

  49. 0.55

    Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease

    Argiris G, Akinci M, Pena-Gomez C et al. · Alzheimer's research & therapy · 2024

  50. 0.55

    CSF alpha-synuclein aggregation is associated with APOE epsilon4 and progressive cognitive decline in Alzheimer's disease

    Qiang Q, Skudder-Hill L, Toyota T et al. · Neurobiology of aging · 2025

  51. 0.55

    The Effects of CSF Neurogranin and APOE epsilon4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease

    Fan Y, Gao Y, Therriault J et al. · Frontiers in aging neuroscience · 2021

  52. 0.54

    Telomere length associations with cognition depend on Alzheimer's disease biomarkers

    Mahoney ER, Dumitrescu L, Seto M et al. · Alzheimer's & dementia (New York, N. Y.) · 2019

  53. 0.53

    Apolipoprotein E epsilon4 and epsilon3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-beta in mild cognitive impairment but not in Alzheimer's disease

    Xing F, Meng T, Therriault J et al. · Journal of integrative neuroscience · 2021

  54. 0.53

    Growth-Associated Protein 43 Levels in the Cerebrospinal Fluid Correspond to the Cerebral Blood Flow Alterations in Alzheimer's Dementia Continuum: An Original Study

    Songhori N, Goushky MS, Khaleghi MM et al. · Health science reports · 2025

  55. 0.53

    APOE epsilon4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease

    Wang S, Zhang J, Pan T · Neuroscience letters · 2018

  56. 0.53

    Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease

    Pettigrew C, Soldan A, Sloane K et al. · NeuroImage. Clinical · 2017

  57. 0.53

    Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline

    Thomas KR, Bangen KJ, Weigand AJ et al. · Alzheimer disease and associated disorders · 2020

  58. 0.53

    Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults

    Sible IJ, Nation DA · Neurology · 2022

  59. 0.52

    CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and ApoE4

    Greenberg BD, Pettigrew C, Soldan A et al. · Neurology · 2022

  60. 0.52

    The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

    Bos I, Vos S, Vandenberghe R et al. · Alzheimer's research & therapy · 2018

  61. 0.52

    Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease

    Roe CM, Fagan AM, Williams MM et al. · Neurology · 2011

  62. 0.51

    Coupled sleep rhythm disruption predicts cognitive decline in Alzheimer's disease

    Wei T, Zhou J, Wang Z et al. · Science bulletin · 2025

  63. 0.50

    Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age

    Ballarini T, Melo van Lent D, Brunner J et al. · Neurology · 2021

  64. 0.50

    Modeling the age-specific incidence of mild cognitive impairment incorporating the time-varying relationship of Alzheimer's disease biomarkers over 28 years

    Wang K, Zhu Y, Albert M et al. · Journal of Alzheimer's disease : JAD · 2026

  65. 0.50

    APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern

    Risacher SL, Kim S, Nho K et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015

06mci · mild37편

  1. 0.92

    Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype

    Albert M, Soldan A, Gottesman R et al. · Current Alzheimer research · 2014

  2. 0.89

    Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults

    Corsentino EA, Sawyer K, Sachs-Ericsson N et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2009

  3. 0.82

    APOE epsilon2epsilon4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults

    Oveisgharan S, Buchman AS, Yu L et al. · Neurology · 2018

  4. 0.80

    Sex differences in the association of APOE epsilon4 genotype with longitudinal hippocampal atrophy in cognitively normal older people

    Shen S, Zhou W, Chen X et al. · European journal of neurology · 2019

  5. 0.75

    The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study

    Brainerd CJ, Reyna VF, Petersen RC et al. · Neuropsychology · 2013

  6. 0.74

    The influence of APOE status on rate of cognitive decline

    Morrison C, Oliver MD, Berry V et al. · GeroScience · 2024

  7. 0.71

    Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects

    Tervo S, Kivipelto M, Hanninen T et al. · Dementia and geriatric cognitive disorders · 2004

  8. 0.71

    Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults

    Weigand AJ, Bondi MW, Thomas KR et al. · Neurology · 2020

  9. 0.69

    Subjective cognitive decline, APOE epsilon4, and incident mild cognitive impairment in men and women

    Muller-Gerards D, Weimar C, Abramowski J et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2019

  10. 0.68

    Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment

    Nosheny RL, Insel PS, Truran D et al. · Neurobiology of aging · 2015

  11. 0.67

    Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE epsilon4 Genotype

    Krell-Roesch J, Vemuri P, Pink A et al. · JAMA neurology · 2017

  12. 0.67

    Prevalence and correlates of dementia and mild cognitive impairment classified with different versions of the modified Telephone Interview for Cognitive Status (TICS-m)

    Lindgren N, Rinne JO, Palviainen T et al. · International journal of geriatric psychiatry · 2019

  13. 0.66

    APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment

    Dixon RA, DeCarlo CA, MacDonald SWS et al. · Frontiers in aging neuroscience · 2014

  14. 0.66

    Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study

    Brainerd CJ, Reyna VF, Petersen RC et al. · Neuropsychology · 2011

  15. 0.62

    Risk Factors for Mild Cognitive Impairment, Dementia and Mortality: The Sydney Memory and Ageing Study

    Lipnicki DM, Crawford J, Kochan NA et al. · Journal of the American Medical Directors Association · 2017

  16. 0.62

    Role of depression in predicting time to conversion to mild cognitive impairment

    Dean K, Oulhaj A, Zamboni G et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2014

  17. 0.61

    Sydney Memory and Ageing Study: an epidemiological cohort study of brain ageing and dementia

    Tsang RSM, Sachdev PS, Reppermund S et al. · International review of psychiatry (Abingdon, England) · 2013

  18. 0.60

    Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE varepsilon4 Allele Carriers

    Kadey KR, Woodard JL, Moll AC et al. · Journal of Alzheimer's disease : JAD · 2021

  19. 0.60

    A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings

    Baumeister H, Vogel JW, Insel PS et al. · Brain : a journal of neurology · 2024

  20. 0.58

    Self-reported cognitive decline on the informant questionnaire on cognitive decline in the elderly is associated with dementia, instrumental activities of daily living and depression but not longitudinal cognitive change

    Eramudugolla R, Cherbuin N, Easteal S et al. · Dementia and geriatric cognitive disorders · 2012

  21. 0.58

    News event memory in amnestic and non-amnestic MCI, heritable risk for dementia, and subjective memory complaints

    Asp I, Cawley-Bennett ATJ, Frascino JC et al. · Neuropsychologia · 2024

  22. 0.58

    The Risk of Incident Mild Cognitive Impairment and Progression to Dementia Considering Mild Cognitive Impairment Subtypes

    Michaud TL, Su D, Siahpush M et al. · Dementia and geriatric cognitive disorders extra · 2017

  23. 0.56

    Age-dependent effects of APOE epsilon4 in preclinical Alzheimer's disease

    Bonham LW, Geier EG, Fan CC et al. · Annals of clinical and translational neurology · 2016

  24. 0.56

    Mild cognitive impairment among rural-dwelling older adults in China: A community-based study

    Cong L, Ren Y, Wang Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  25. 0.56

    Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging

    Pankratz VS, Roberts RO, Mielke MM et al. · Neurology · 2015

  26. 0.55

    Risk and protective factors for cognitive impairment in persons aged 85 years and older

    Roberts RO, Cha RH, Mielke MM et al. · Neurology · 2015

  27. 0.54

    Association of prior stroke with cognitive function and cognitive impairment: a population-based study

    Knopman DS, Roberts RO, Geda YE et al. · Archives of neurology · 2009

  28. 0.54

    Bidirectional transitions between subjective cognitive decline and normal cognition and risk of mild cognitive impairment: A multistate Markov model study in NACC UDS

    Xiao Y, Zhou Z, Jin M et al. · Journal of Alzheimer's disease : JAD · 2026

  29. 0.54

    Word-list intrusion errors predict progression to mild cognitive impairment

    Thomas KR, Eppig J, Edmonds EC et al. · Neuropsychology · 2018

  30. 0.52

    Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort

    Chen Y, Denny KG, Harvey D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017

  31. 0.52

    Accelerated progression from mild cognitive impairment to dementia among APOE epsilon4epsilon4 carriers

    Xu WL, Caracciolo B, Wang HX et al. · Journal of Alzheimer's disease : JAD · 2013

  32. 0.51

    Predictors of Incident Mild Cognitive Impairment and Its Course in a Diverse Community-Based Population

    Angevaare MJ, Vonk JMJ, Bertola L et al. · Neurology · 2022

  33. 0.51

    Cognitive variability-A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative

    Anderson ED, Wahoske M, Huber M et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2016

  34. 0.50

    Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative

    Grill JD, Di L, Lu PH et al. · Neurobiology of aging · 2013

  35. 0.50

    Conversion to Mild Cognitive Impairment and Alzheimer's Disease Dementia Related to Apathy, APOE Genotype and Antidepressant Use

    Malik R, Martinez MR, So I et al. · Journal of geriatric psychiatry and neurology · 2025

  36. 0.50

    Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid beta-Associated Cognitive Decline in Older Adults

    Dang C, Harrington KD, Lim YY et al. · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2019

  37. 0.50

    Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults

    Jang JY, Ho JK, Blanken AE et al. · Journal of Alzheimer's disease : JAD · 2020

07plasma · biomarkers35편

  1. 0.89

    APOE epsilon4 status and plasma p-tau181 interact to influence cognitive performance among non-demented older adults

    Wang S, Ke S, Liu S et al. · Neuroscience letters · 2023

  2. 0.86

    Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE epsilon4 carriers

    Yang J, Wang J, Chai W et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  3. 0.80

    Validation of longitudinal change in proper name recall with pTau217 as a marker of early cognitive decline in cognitively unimpaired adults at risk for Alzheimer's disease dementia

    Basche K, He D, Langhough R et al. · Journal of Alzheimer's disease : JAD · 2026

  4. 0.79

    Proteomic analysis of APOEepsilon4 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience

    Walker KA, An Y, Moghekar A et al. · Molecular neurodegeneration · 2024

  5. 0.79

    APOEepsilon4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial

    Zeng Y, Du W, Zhang M et al. · Brain sciences · 2024

  6. 0.78

    Ancestry-specific effects of APOE on Alzheimer Disease Endophenotypes

    Boeriu AI, Gu T, Fullton-Howard B et al. · medRxiv : the preprint server for health sciences · 2026

  7. 0.76

    Higher soluble ADAM10 plasma levels are associated with decreased cognitive performance in older adults carrying APOEepsilon4

    Pelegrini LNdC, Manzine PR, Popolin CP et al. · Neurobiology of aging · 2025

  8. 0.75

    The association of human apolipoprotein epsilon4 with dementia, cognition, imaging, and plasma biomarkers of neurodegeneration in a sample of older adults in the Democratic Republic of the Congo

    Ikanga J, Patel SS, Schwinne M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  9. 0.74

    Sleep and APOE-epsilon4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults

    Yu X, Zhou X, He Z et al. · CNS neuroscience & therapeutics · 2024

  10. 0.74

    APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia

    Wang S, Liu S, Ke S et al. · Journal of Alzheimer's disease : JAD · 2023

  11. 0.72

    Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals

    Jack CRJ, Wiste HJ, Algeciras-Schimnich A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  12. 0.71

    The Relationship Between Gait Task Performance and Plasma Biomarkers for Alzheimer's Disease in Cognitively Unimpaired Older Adults and Patients with Mild Cognitive Impairment

    Sergio J, Price A, Snyder PJ et al. · Clinical interventions in aging · 2026

  13. 0.71

    Correlation Between Urine Formaldehyde and Cognitive Abilities in the Clinical Spectrum of Alzheimer's Disease

    Wang Y, Pan F, Xie F et al. · Frontiers in aging neuroscience · 2022

  14. 0.69

    Motor speech markers of Alzheimer's risk

    Giffard J, Bindoff AD, Roccati E et al. · GeroScience · 2026

  15. 0.68

    Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies

    Xu Y, Gunasekaran TI, Gu Y et al. · The Lancet. Neurology · 2026

  16. 0.66

    Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort

    Ferreira PCL, Zhang Y, Snitz B et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  17. 0.66

    APOE epsilon4 accelerates plasma p-tau217 trajectory: a Bayesian joint longitudinal analysis of ADNI

    Chu KY · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026

  18. 0.61

    A plasma protein signature associated with cognitive function in men without severe cognitive impairment

    Mehta K, Mohebbi M, Pasco JA et al. · Alzheimer's research & therapy · 2023

  19. 0.61

    Association of plasma YKL-40 with brain amyloid-beta levels, memory performance, and sex in subjective memory complainers

    Vergallo A, Lista S, Lemercier P et al. · Neurobiology of aging · 2020

  20. 0.59

    Detecting Preclinical Alzheimer's Disease Risk in Cognitively Normal Adults Using Speech Acoustics: Validation with Plasma p-Tau217 and APOE-epsilon4 Status

    Dadgostar M, Hanford LC, Tavakoli M et al. · medRxiv : the preprint server for health sciences · 2026

  21. 0.59

    Plasma inflammatory biomarker profiles across the Alzheimer's disease spectrum in the Bio-Hermes cohort

    Hussain Z, Ng D, Leighton S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  22. 0.59

    The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults

    Sewell KR, Rainey-Smith SR, Pedrini S et al. · GeroScience · 2024

  23. 0.58

    APOE genotype and astrocyte activity collectively influence AD biomarkers and Abeta burden

    Chen W, Su F, Kong H et al. · Brain research · 2026

  24. 0.58

    Impact of COVID-19 pandemic on cognitive decline in community-dwelling older adults in Shanghai: a longitudinal study from 2010 to 2024

    Zhou X, Deng H, Shao H et al. · The Lancet regional health. Western Pacific · 2025

  25. 0.58

    Associations of plasma p-tau231 with serial position recall performance in free-of-dementia individuals

    Bruno D, Reichert-Plaska C, Jauregi-Zinkunegi A et al. · Journal of neuropsychology · 2026

  26. 0.57

    Plasma biomarker trajectories: Impact of AD genetic risk and clinical progression

    Pettigrew C, Soldan A, Wang J et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  27. 0.55

    Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study

    Baldacci F, Lista S, Manca ML et al. · Alzheimer's research & therapy · 2020

  28. 0.54

    Association of plasma biomarkers with cognitive function in persons with dementia and cognitively healthy in the Democratic Republic of Congo

    Ikanga J, Patel SS, Roberts BR et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2023

  29. 0.53

    APOE epsilon4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors

    Cooper JG, Ghodsi M, Stukas S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  30. 0.52

    Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Abeta ratio

    Capuano AW, Bennett DA, Dage JL et al. · medRxiv : the preprint server for health sciences · 2025

  31. 0.52

    Incremental value of plasma biomarkers in predicting clinical decline among cognitively unimpaired older adults: Results from the A4 trial

    Khorsand B, Ghanbarian E, Rabin LA et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  32. 0.51

    Astrocytic function is associated with both amyloid-beta and tau pathology in non-demented APOE ϵ4 carriers

    Spotorno N, Najac C, Stomrud E et al. · Brain communications · 2022

  33. 0.50

    Plasma Phosphorylated Tau 217 and Incident Mild Cognitive Impairment and Dementia in Older Women

    Shadyab AH, Zhang B, LaCroix AZ et al. · JAMA network open · 2026

  34. 0.50

    Plasma Proteomic Analysis of APOE epsilon4 Homozygotes Identifies Preclinical Alzheimer's Disease Alterations Potentially Treatable with Semaglutide

    Dammer EB, Afshar S, Bian S et al. · medRxiv : the preprint server for health sciences · 2026

  35. 0.50

    Detection of beta-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers

    Tosun D, Veitch D, Aisen P et al. · Brain communications · 2021

08trial · intervention26편

  1. 0.90

    Apolipoprotein E epsilon4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial

    Liu X, Sacks FM, Beck T et al. · The American journal of clinical nutrition · 2025

  2. 0.89

    Does APOE varepsilon4 Status Change How 24-Hour Time-Use Composition Is Associated with Cognitive Function? An Exploratory Analysis Among Middle-to-Older Adults

    Dumuid D, Mellow ML, Olds T et al. · Journal of Alzheimer's disease : JAD · 2022

  3. 0.88

    APOE4 carriers resistant to cognitive decline show unique relationships between cerebrovascular response to exercise and dual-task cognitive-balance performance

    Palmer JA, Billinger SA · Frontiers in neuroscience · 2026

  4. 0.86

    Longitudinal deterioration of subjective cognitive decline in apolipoprotein epsilon4 carriers and improvement of subjective cognitive decline by multi-domain intervention for prevention of dementia: The cognitive function instrument assessment

    Osaki T, Oki Y, Kumagai R et al. · Journal of Alzheimer's disease : JAD · 2025

  5. 0.86

    Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme

    Alfred T, Ben-Shlomo Y, Cooper R et al. · Age (Dordrecht, Netherlands) · 2014

  6. 0.84

    APOE4 carriers resistant to cognitive decline show unique relationships between cerebrovascular response to exercise and dual-task cognitive-balance performance

    Palmer JA, Billinger SA · bioRxiv : the preprint server for biology · 2025

  7. 0.84

    Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction

    Gordon S, Hoey L, McNulty H et al. · BMC medicine · 2025

  8. 0.83

    Cardiorespiratory fitness, independent of APOE genotype, is associated with better neurocognitive function in older adults: An ERP study

    Chang YK, Etnier JL, Li RH et al. · Psychology of sport and exercise · 2025

  9. 0.83

    The influence of a 16-week exercise program, APOE status, and age on executive function task performance: A randomized trial

    Martin-Willett R, Morris B, Wilcox R et al. · Experimental gerontology · 2021

  10. 0.81

    The Physical Activity and Alzheimer's Disease (PAAD) Study: Cognitive outcomes

    Etnier JL, Karper WB, Labban JD et al. · Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2018

  11. 0.81

    Physical activity domains and cognitive function over three years in older adults with subjective memory complaints: Secondary analysis from the MAPT trial

    de Souto Barreto P, Andrieu S, Rolland Y et al. · Journal of science and medicine in sport · 2018

  12. 0.81

    APOE epsilon4 carrier status moderates the effect of lifestyle factors on cognitive reserve

    O'Shea DM, Zhang AS, Rader K et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  13. 0.80

    An 18-mo randomized, double-blind, placebo-controlled trial of DHA-rich fish oil to prevent age-related cognitive decline in cognitively normal older adults

    Danthiir V, Hosking DE, Nettelbeck T et al. · The American journal of clinical nutrition · 2018

  14. 0.80

    The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

    Donohue MC, Sperling RA, Salmon DP et al. · JAMA neurology · 2014

  15. 0.80

    Acute Exercise Effect on Neurocognitive Function Among Cognitively Normal Late-Middle-Aged Adults With/Without Genetic Risk of AD: The Moderating Role of Exercise Volume and APOE Genotype

    Chang YK, Etnier JL, Li RH et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2024

  16. 0.79

    Structured Cognitive Training Yields Best Results in Healthy Older Adults, and Their ApoE4 State and Baseline Cognitive Level Predict Training Benefits

    Roheger M, Kessler J, Kalbe E · Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2019

  17. 0.78

    Impact of the Apolipoprotein E epsilon4 Allele on Cognition and Omega-3 Fatty Acid Levels in the Plasma Membrane of Red Blood Cells in Healthy Elderly Japanese Population

    Hashimoto M, Matsuzaki K, Matsuda C et al. · Dementia and geriatric cognitive disorders extra · 2025

  18. 0.76

    Age and APOE genotype affect the relationship between objectively measured physical activity and power in the alpha band, a marker of brain disease

    de Frutos-Lucas J, Cuesta P, Ramirez-Torano F et al. · Alzheimer's research & therapy · 2020

  19. 0.72

    Positive Effect of Cognitive Training in Older Adults with Different APOE Genotypes and COVID-19 History: A 1-Year Follow-Up Cohort Study

    Zorkina Y, Syunyakov T, Abramova O et al. · Diagnostics (Basel, Switzerland) · 2022

  20. 0.63

    CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial

    Yassine HN, Pour SG, Juarez M et al. · EBioMedicine · 2026

  21. 0.60

    Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohort

    Cerin E, Rainey-Smith SR, Ames D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017

  22. 0.60

    Red blood cell omega-3 status and longitudinal cognition in individuals at risk of Alzheimer disease

    Lazaro I, Brugulat-Serrat A, Suarez-Calvet M et al. · The Journal of nutrition · 2025

  23. 0.58

    24-Hour time use and cognitive performance in late adulthood: results from the Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE) study

    Collins AM, Mellow ML, Smith AE et al. · Age and ageing · 2025

  24. 0.57

    Effect modifiers of the MIND diet for cognition in older adults: The MIND diet trial

    Halloway S, Aggarwal NT, Arfanakis K et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  25. 0.57

    Telomere Length Change in a Multidomain Lifestyle Intervention to Prevent Cognitive Decline: A Randomized Clinical Trial

    Sindi S, Solomon A, Kareholt I et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2021

  26. 0.54

    Baseline predictors of neurophysiological response to combined physical and cognitive training in older adults with subjective cognitive decline

    Chiu HC, Hsieh YW, Cheng CH · BMC geriatrics · 2026